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ABSTRACT
Introduction: Exercise increases skeletal muscle glucose uptake via AMP-activated
protein kinase (AMPK) activation and GLUT4 translocation from cytosol to cell
membrane. It also promotes glucose utilisation in type 2 diabetic patients via
increased insulin sensitivity. Insulin stimulates GLUT4 translocation by activating P13-
kinase and protein kinase B (PKB/Akt). We therefore postulated that a connection
exists between these two pathways upstream of GLUT4 translocation. Understanding
this connection is important in the development of treatment strategies for type 2
diabetes. This exercise-induced increase in AMP-activated protein kinase (AMPK)
activation can be mimicked by a pharmacological agent, 5'-aminoimidazole-4-
carboxamide ribonucleoside (AlGAR), which is converted intracellularly into 5'-
aminoimidazole-4-carboxamide-ribonucleosidephosphate (ZMP), an AMP analogue.
Aim: To investigate the effect of two pharmacological AMPK-activating compounds,
ZMP and AlGAR, on the phosphorylation of AMPK, the phosphorylation of PKB/Akt
as well as possible feedback on insulin-stimulated glucose uptake and GLUT4
translocation.
Materials and Methods: Adult ventricular cardiomyocytes were isolated from male
Wistar rats by collagenase perfusion and treated with 1 mM AlGAR or 1 mM ZMP in
the presence or absence of 100 nM insulin or 100 nM wortmannin, an inhibitor of P13-
kinase. Glucose uptake was measured via eH]-2-deoxyglucose (2DG) accumulation.
PKB/Akt and AMPK phosphorylation and GLUT4 translocation was detected by
Western blotting. Purinergic receptors were blocked with 8-cyclopentyl-1,3-
III
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dipropylxanthine (8CPT) and the effect on AMPK phosphorylation noted. Certain
results were confinned or refuted by repeating experiments using the isolated rat
heart model.
Results: AICAR and ZMP promoted AMPK phosphorylation. Neither drug increased
glucose uptake but in fact inhibited basal glucose uptake, although GLUT4
translocation from cytosol to membrane occurred. Both compounds also attenuated
insulin stimulated glucose uptake. Wortmann in abolished glucose uptake and
PKB/Akt phosphorylation elicited by insulin while, in the presence of wortmannin,
AICAR and ZMP increased levels of PKB/Akt phosphorylation. Although AICAR and
ZMP increased glucose uptake in skeletal muscle, this was not seen in
cardiomyocytes. However both compounds increased GLUT4 translocation, clearly
demonstrating that translocation and activation of GLUT4 are separate processes.
8CPT had no effect on the phosphorylation of AMPK by either AICAR or ZMP
indicating that there was no involvement of the purinergic receptors.
Conclusion: Although AICAR and ZMP increase glucose uptake in skeletal muscle,
this was not seen in cardiomyocytes. Conversely, both compounds inhibited both
basal and insulin stimulated glucose uptake despite increasing GLUT4 translocation.
Inhibition of Pl3-kinase in presence or absence of insulin unmasked hitherto
unknown effects of AICAR and ZMP on PKB phosphorylation.
IV
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UITTREKSEL
Agtergrond: Oefening verhoog skeletspier glukose opname via AMP-geaktiveerde
protein kinase (AMPK) aktivering en GLUT4 translokering vanaf die sitosol na die
selmembraan. Dit verbeter ook glukose verbruik in tipe 2 diabetes pasiënte via
verhoogde insulien sensitiwiteit. Insulien stimuleer GLUT4 translokering deur P13-
kinase en protein kinase B (PKB/Akt) te aktiveer. Dit word dus gepostuleer dat daar
'n verbinding tussen hierdie twee paaie, wat beide betrokke is by GLUT4
translokering, bestaan. Dit is belangrik om hierdie verbinding te verstaan aangesien
dit in behandelingstrategieë van tipe 2 diabetes geteiken kan word. Die oefening
geïnduseerde verhoging in AMPK aktivering, kan deur 'n farmakologiese middel 5'-
aminoimidasool-4-karboksamied ribonukleosied (AICAR), wat intrasellulêr omgesit
word na 5'-aminoimidasool-4-karboksamied-ribonukleosiedfosfaat (ZMP), 'n AMP
analoog, nageboots word.
Doel: Om die effek van twee farmakologiese AMPK-aktiveringsmiddels, AICAR en
ZMP, op die fosforilering van AMPK en PKB/Akt, sowel as moontlike effekte daarvan
op insulien-gestimuleerde glukose opname en GLUT4 translokering, te ondersoek.
Materiale en Metodes: Volwasse ventrikulêre kardiomiosiete is uit manlike Wistar
rotharte geïsoleer d.m.v kollagenase perfusies en behandel met 1 mM AICAR of 1
mM ZMP in die teenwoordigheid of afwesigheid van 100 nM insulien of 100 nM
wortmannin. Glukose opname is gemeet via intrasellulêre [3H]-2-deoksiglukose
akkumulasie; PKB/Akt en AMPK fosforilering sowel as GLUT4 translokering is bepaal
deur Western blot analises. Purinergiese reseptore is geblokkeer met 8-siklopentiel-
1,3-dipropielxanthien (8CPT) en die effek daarvan op AMPK fosforilering genoteer.
v
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Ten einde resultate wat in die geïsoleerde kardiomiosiet-model verkry is, te bevestig,
is sekere eksperimente in die geïsoleerde rothart herhaal.
Resultate: Beide AlGAR en ZMP stimuleer AMPK fosforilering. Die middels kan nie
glukose opname verhoog nie, inteendeel, basale glukose opname is onderdruk
alhoewel GLUT4 translokering vanaf die sitosol na die selmembraan wel plaasgevind
het. Wortmannin kon insulien gemedieerde glukose opname en PKB/Akt fosforilering
onderdruk. In die teenwoordigheid van wortmannin het beide AlGAR en ZMP
PKB/Akt fosforilering verhoog. Alhoewel beide AlGAR en ZMP glukose opname in
skeletspier verhoog, was dit nie die geval in kardiomiosiete nie. Beide middels het
wel GLUT4 translokering verhoog, wat duidelik demonstreer dat die translokering en
aktivering van GLUT4, verskillende prosesse is. 8GPT het geen effek gehad op die
fosforilering van AMPK deur AlGAR of ZMP nie, wat bewys dat daar geen
betrokkenheid van die purinergiese reseptore was nie.
Gevolgtrekking: Alhoewel AlGAR en ZMP glukose opname in skeletspier verhoog is
dit nie die geval in kardiomiosiete nie. Beide middels inhibeer basale en insulien-
gestimuleerde glukose opname maar stimuleer GLUT4 translokeering. Inhibisie van
Pl3-kinase in die teenwoordigheid of afwesigheid van insulien, ontmasker voorheen
onbekende effekte van AlGAR en ZMP op PKB/Akt fosforilering.
VI
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CHAPTER 1
INTRODUCTION
The energy that the heart requires for maintenance of normal contraction is supplied
by adenosine triphosphate (ATP), and this high-energy phosphate is primarily
produced in the heart by the metabolism of carbohydrates and fatty acids (Lopaschuk
& Stanley, 1997). Substrate metabolism varies between carbohydrates as fuel in the
fed state, of which glucose and lactate are the major contributors, and fatty acids in
the fasting state (Wang et aI, 1999; Sakamoto et aI, 2000). This is due to the fact that
in the fed state there are more carbohydrates available in the blood, and in the
fasting state there are more free fatty acids (FFA) available. In the latter case, fatty
acid oxidation occurs predominantly, and glucose oxidation is inhibited (Opie, 1991).
The glucose that is taken up is converted to glycogen and stored instead of
undergoing glycolysis (Randle et aI, 1963). Conversely, in the carbohydrate-fed-
state, when glucose levels are high in the blood, the uptake of fatty acids decreases
while glucose uptake and glycolysis increases (Opie, 1998).
1.1 Randle's Principle and Pasteur Effect
The variation in the roles of glucose and fatty acid between the fasting and the fed
states forms the basis of the glucose-fatty acid cycle first described by Randle et al
(1963). The basic trigger in the cycle is the cyclic production of FFA by the adipose
tissue (see Figure 1.1). In the fasting state, adipose tissue is
1
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MUSCLE BLOOD PLASMA ADIPOSE TISSUE
GLUCOSE
1
FATTY ACIDS
KETONt BODIES
Figure 1.1. Glucose-fatty acid cycle, blood phase. 1. Glucose uptake by muscle
and adipose tissue. 2. Release of fatty acids from adipose tissue into plasma.
3. Formation of ketone bodies from fatty acids by liver and 4. Fatty acid uptake
and ketone body uptake by muscle tissue. (Figure adapted from Randle et ai,
1963).
GLUCOSE 4 L-GL YCEROL - 3 - PHOSPHATE
FATTY ACID CYC
3 TRIGLYCERIDE
Figure 1.2 Glucose fatty-acid cycle, tissue phase. 1. Esterification, 2. Lypolysis,
3. Fatty acid activation and 4. Glycerol phosphate synthesis. (From Randle et
al, 1963)
2
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broken down to release FFA and this inhibits the metabolism of glucose by the heart.
In the fed state the abundance of glucose and insulin inhibits this release of FFA and
therefore glucose becomes the major fuel (see Figure 1.2).
These events require complex control mechanisms, as will be discussed later in
Chapter 2.1.2 and 2.2.
Although glucose is not the major fuel for either the normal beating heart (Bing et ai,
1954) or during mild to moderate exercise (Zierier et al, 1999), it is an important
metabolic fuel in cardiomyocytes. It is stored as glycogen, and becomes the primary
fuel of these cells during fasting or hypoxic conditions (Opie 1991, 1998). This is
because, when the oxygen supply to the heart is normal the rate of glycolysis is
inhibited by high levels of citrate and ATP formed by oxidative metabolism in the
citrate cycle (Randle & Morgan, 1962). When the oxygen supply is inhibited or
decreased this oxidative metabolism is inhibited, citrate and ATP levels fa" and
glycolysis is stimulated (see Fig 1.3). This feedback mechanism is known as the
Pasteur Effect.
3
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CARBOHYDRATES FATTY ACIDS
GLYCOGEN
ti
GLUCOSL. G-Q-P
FFA
t
ACYL-CoA
INTRAMITOCHONDRIAL
ACYLCoA
OXIDATION SPIRAL
ACETYL-CoA
2HLACTATE _,. pyruvate
Amino acids
32 ATP per glucose
105 ATP per
palmitate
KREBS' ICITRATE CYCLE ADP
Figure 1.3 Major fuels of the heart are carbohydrates (glucose and lactate) and
non-esterified fatty acids (FFA). All fuels are ultimately broken down to acetyl-
CoA, which produces hydrogen atoms (H+)by various dehydrogenase enzymes
to produce NADH2(NADH + H+),which enters the respiratory chain to produce
ATP. Fatty acids also produce FADH2 from the oxidation spiral which enters
the cytochrome chain and produces AlP. (Adapted from Depré et ai, 1998 and
Opie 2004).
4
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CHAPTER2
LITERATURE REVIEW
2.1 Glucose Uptake and Metabolism
2.1.1 Glucose Uptake
Glucose uptake into muscle cells is accomplished through a series of steps and
signaling pathways, from the delivery of blood to the interstitial space to the trans-
membrane transport of glucose into the cell (Richter et al 2001). The cell cannot
absorb glucose by simple diffusion, since the cell membrane is hydrophobic and
glucose is hydrophilic. It must instead use a special carrier protein, the glucose
transporter molecule, for this purpose. (Lienhard et aI, 1992). This carrier requires no
energy for transport of glucose since the extracellular glucose concentration is so
much greater than the intracellular concentration (Opie, 1991).
2.1.2 Glucose transporters (GLUTs)
As stated above, the uptake of glucose from the blood stream across the
sarcolemma and into the heart cells is regulated and carried out by the glucose
transporters or GLUTs (Pessin & Bell, 1992; Lopasenuk & Stanley, 1997). The
specific glucose transporters in the heart all belong to the GLUT family and are
encoded by different nuclear genes. They are transmembrane proteins containing
5
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about 500 amino acid residues and 12 membrane-spanning l3-helices, five of which
could form a hydrophilic channel responsible for glucose transport (Meukier, 1994).
The glucose transporter that is predominantly expressed in cardiomyocytes is the
insulin-sensitive GLUT4-isotype which is also expressed in adipose tissue and
skeletal muscle. GLUT4 is largely confined to an intracellular vesicle storage site in
the basal, non-stimulated state (Meukier, 1994; Holman & Kasuga, 1997). It becomes
recruited to the cell surface under the influence of insulin (Fischer et aI, 1997; Calera
et aI, 1998; Becker et aI, 2001) or other stimuli such as contraction and hypoxia or
anoxia. GLUT4 vesicles respond to insulin in a marked and dramatic waY', increasing
GLUT4 in the membrane up to nine times that of basal (Holloszy, 2003). When blood
insulin and glucose levels decrease, then the transporter recruitment is reversed
(Lienhard et al, 1992).
The GLUT1-transporter, which is present in most tissues and is also a characteristic
feature of fetal tissues (Depre et aI, 1998), is also present in cardiomyocytes although
it is about 5 times less abundant than GLUT4 (Meukier, 1994). It is thought to be a
specialized "house-keeping" protein to provide the steady basal flow of glucose into
cells for homeostasis in their inactive state.
While there is substantial evidence that the GLUT4 transporter exists in specialized
vesicles within the cell (Saltiel & Pessin, 2003), the precise intracellular location and
trafficking pathways of these vesicles are unclear. GLUT4 is localized in
6
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tubulovesicular and vesicular structures that are biochemically distinct from the
recycling endosomal network. Furthermore the GLUT4 compartment is enriched in
the v-SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor)
protein VAMP2 (Pessin et ai, 1999). There is also evidence to suggest that the
plasma membrane target for the GLUT4 vesicle is the t-SNARE syntaxin 4 (Syn4)
(Cheatham et al, 1996; Volchuk et al, 1996; Rea & James 1997; Olson et al, 1997).
Thus the docking of vesicles may be mediated by the interaction of the Syn4 with the
GLUT4 vesicle v-SNARE protein, VAMP2 (Saltiel & Pessin, 2003).
In 2001 Somwar and colleagues found that there was a delay of 2 minutes between
the arrival of GLUT4 at the membrane and the observation of any increase in glucose
uptake. This suggested that an intermediate existed which activated GLUT4 before
glucose uptake could occur. Evidence has been presented by Konrad et al (2001)
and Somwar et al (2001, 2002) that suggests a role for p38 mitogen-activated protein
kinase (p38 MAPK) in the activation of GLUT4 by insulin. Konrad and colleagues
showed that S8203580, an inhibitor of p38 MAPK, attenuated insulin-stimulated
glucose uptake without altering GLUT4 translocation. These results suggested that
insulin might activate GLUT4 via a p38 MAPK-dependent pathway, and that GLUT4
translocation and GLUT4 activation to take up glucose may be two independent
events.
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2.1.3 Glucose Metabolism
Glucose metabolism has two main components, glycolysis and glucose oxidation.
(See fig 2.1)
Glycolysis
Glycolysis ('lysis of glucose') is the first part of the glucose metabolic pathway and
produces ATP from either exogenous glucose or from glycogen without requiring
oxygen (Depre ef aI, 1998). It is the biochemical process that produces lactate in
anaerobic conditions (Opie, 1991). During normal oxidative metabolism, glycolysis
yields pyruvate, which is then broken down aerobically in the citrate cycle (under
adequate mitochondrial capacity). This process is also called aerobic glycolysis. Thus
ATP is produced not only during aerobic conditions, but anaerobically too (Opie,
1991).
Intracellular glucose is rapidly converted into glucose-6-phosphate by hexokinase,
and glycolysis then converts this into a compound containing two phosphate groups,
fructose-1,6-bisphosphate. After this, each 6-carbon hexose phosphate is converted
into two three-carbon triose phosphates, eventually forming pyruvate. In the first
stage, two molecules of ATP are used per glucose molecule converted to two triose
phosphate molecules. In the second stage four molecules of ATP are made,
independently of oxygen, for each glucose 6-phosphate converted to pyruvate,
8
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resulting in a net production of 2 molecules of ATP per molecule of glucose
metabolized.
The role of the enzyme phosphofructokinase (PFK) is of great importance. When its
activity increases, as in hypoxia, glucose-6-phosphate is converted to fructose-6-
phosphate at an increased rate and this reaction, which uses ATP, is irreversible,
since the enzyme which catalyses the reverse reaction is not present in the heart
(Opie, 1998). Thus PFK's activity serves as a one directional valve to regulate the
rate of glycolysis. Increased PFK activity causes decreased glucose-6-phosphate
levels in the cell, therefore the inhibition of hexokinase which is normally caused by
glucose-6-phosphate is decreased, and more glucose can be phosphorylated. In
contrast, the activity of PFK can be inhibited when the oxidation of alternate fuels like
fatty acid or lactate produces citrate, and the opposite then occurs. This is therefore
a coordinated intracellular control. (Opie, 1991; Opie, 1998)
Glycolysis is increased during hypoxia and ischemia and this is controlled by the
activity of two enzymes, PFK and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). The PFK reaction is sensitive to the energy status of the myocardial cells,
and is therefore ideally suited for metabolic control. As ATP levels fall, and those of
ADP, AMP and Pi rise, the activity of this enzyme is enhanced resulting in increased
anaerobic glycolysis (Morgan et ai, 1961).
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At maximal work oads under the same conditions, glyceraldehyde 3-phosphate
dehydrogenase becomes rate-limiting because of the accumulation of nicotinamide
adenine dinucleotide (NADH). Pyruvate oxidation is regulated by pyruvate
dehydrogenase (PDH) activity, and the active enzyme converts pyruvate to acetyl-
CoA (Marks, 1990). In the maximally working heart perfused with insulin and
glucose, pyruvate dehydrogenase is fully active, and the rate-limiting step in glucose
metabolism is NADH oxidation. This is dependent on the transport of reducing
equivalents into the mitochondria (Hue et ai, 1988).
When glucose is the source of glycolysis, the entire glycolytic pathway uses 2 ATP
and produces 4 ATP, so the net production is 2 molecules of ATP. When glycogen is
the source, ATP production is 3 (Opie, 1991).
Glucose oxidation
The other component of glucose metabolism is glucose oxidation and this involves
the pyruvate derived from glycolysis being taken up by the mitochondria and its
further metabolism in the citric acid cycle. Glucose is metabolized in the cytosol to
pyruvate while oxidation occurs entirely in the mitochondria (see Fig 2.1). Pyruvate is
converted to acetyl-CoA by pyruvate dehydrogenase (PDH), which is active when the
concentration of its substrates is high, and relatively inactive when its substrates are
of low concentration. Pyruvate is also formed from lactate in the healthy human heart
(Lopaschuk & Stanley, 1997).
10
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Figure 2.1.Glucose and fatty acid oxidation with the rate limiting steps shown.
Glucose transport is regulated by insulin and the energy state of the cell. In the
well-oxygenated heart, glucose uptake and glycolysis can be accelerated by
heart work and substrate glucose, and partially inhibited by fatty acid
oxidation. PFK phosphofructokinase, PDH pyruvate dehydrogenase, FFA free
fatty acids. (Modified from Opie 1991and McDanielet ai, 1988)
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2.2 Fatty Acid Uptake and Metabolism
2.2.1 Fatty Acid Uptake
Free fatty acids (FFA's) in circulation are bound to albumin, Dissociation from
albumin represents the first step of the cellular uptake process, involving membrane
proteins with high affinity for fatty acids, e.g., fatty acid translocase (FAT/CD 36) or
the membrane fatty acid-binding protein (FABPpm). (Rauch et ai, 1987; Stremmei et
ai, 2001). The higher the circulating FFAI albumin ratio the greater the uptake into the
myocardium. According to the thus created transmembrane concentration gradient,
uncharged fatty acids can flip-flop from the outer leaflet across the phospholipid
bilayer. Eventually feedback systems will limit the uptake i.e. increased tissue acyl-
CoA.
Fatty Acid Translocase (FAT)/CD36
Fatty acid uptake seems to be regulated by translocation of fatty acid
translocase/CD36 (FAT/CD36) from intracellular, presumably endosomal, stores to
the sarcolemma (Luiken et ai, 2003). Insulin and cellular contractions are two
important physiological factors which are able to contribute to this process (Bonen et
al, 2000; Luiken et al, 2002). Wortmannin completely blocked insulin-inducable fatty
acid uptake but had no effect on contraction induced fatty acid uptake. Luiken and
co-workers recently published work (2003) that showed contraction induced
FAT/CD36 translocation in rat cardiomyocytes is mediated though AMP-activated
12
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protein kinase (AMPK) signaling. Channeling fatty acids to the different metabolic
pathways requires activation to acyl-CoA. For this process, the family of fatty acid
transport proteins (FATP 1-5/6) might be relevant because they have been shown to
possess acyl-CoA synthetase activity (Stremmei et ai, 2001).
Fatty Acid Oxidation
The first step in fatty acid oxidation is the activation of fatty acids so that acetyl CoA
is formed and used to generate fatty acyl-CoA. Acyl-CoA molecules are then
transferred from the cytosol to within the mitochondria by a transfer system that
requires camitine.
Camitine palmitoyltransferase (CPT) 1, a key enzyme involved in fatty acid oxidation,
is the rate-limiting enzyme involved in mitochondrial fatty acid uptake (Stanley et ai,
1997). Malonyl-CoA, which is produced by acetyl-CoA carboxylase (ACC), is a potent
inhibitor of CPT 1 and acts at a site distinct from the catalytic site of CPT1. ACC is a
very important determinant of malonyl-CoA levels and fatty acid oxidation rates in the
heart (Awan & Saggerson, 1993, Kudo et ai, 1995). A key kinase responsible for the
control of ACC activity is the AMPK (Sakamoto et ai, 2000) (see Fig 2.2). Thus AMPK
is an important regulator of fatty acid oxidation in the heart, since it phosphorylates
and inactivates ACC, resulting in a decrease in malonyl-CoA production and an
increase in fatty acid oxidation rates (Kudo et ai, 1995). It has been shown that the
heart contains an active malonyl-CoA decarboxylase (MCD) that decarboxylates
malonyl-CoA back to acetyl-CoA (Sakamoto et ai, 2000).
13
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Any activated intracellular fatty acid not oxidized can either be stored as triglycerides
or transformed to structural lipids and incorporated into the membrane.
2.2.2 Fatty Acid Metabolism
The first step in fatty acid oxidation is the activation of fatty acids to acyl-CoA which is
then transferred from the cytosol to within the mitochondria (see fig 2.2). On the outer
surface of the inner mitochondrial membrane, the enzyme CPT1 catalyses the
transfer of the acyl group from CoA to camitine. The fatty acyl group is translocated
across the membrane to the inner surface, where the enzyme CPT" catalyses the
transfer of the acyl group to CoA from the inner matrix. J3-oxidation then converts
intramitochondrial long chain acyl-CoA into acetyl-CoA, and the fatty acid oxidation
spiral then continuously removes acetyl-CoA from the carboxyl end of the chain, in
the TCA (tricarboxylic acid) Cycle. The TCA, Citric Acid, or Krebs cycle is the major
energy producing pathway in the body, and starts with the condensation of
oxaloacetate to acetyl-GoA by citrate synthase to form citrate. As acetyl-CoA is
oxidized to CO2, electrons are donated to the oxidation-reduction coenzymes, FAD
and NAD+. Three NADH, 1 FADH2, and 1 GTP are produced in the Citric Acid Cycle.
The NADH and FADH2 generate ATP by donating electrons to O2 in the process of
oxidative phosphorylation. ATP is also produced from GTP (substrate-level
phosphorylation). One tum of the cycle generates 12 ATP molecules. (Marks, 1990,
Davidson and Sittman, 1994).
14
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Figure 2.2 A simplified schematic diagram showing the role of ACC, AMPK, and MCD
in the regulation of fatty acid and glucose oxidation in the heart. Fatty acids are
converted to fatty acyl-CoA by FACS. These fatty acyl-CoA esters are then converted
to fatty acyl camitines and shuttled into the mitochondria via the camitine translocase
system. Once inside the mitochondria, the fatty acyl camitines are converted back into
fatty acyl-CoA esters and enter into the f3-oxidation spiral to produce acetyl-CoA. In
addition, exogenous glucose is transported into the cell via the cell glucose
transporters, and can be converted to pyruvate via glycolysis. Pyruvate enters the
mitochondria via the pyruvate carrier and is converted to acetyl-CoA by the pyruvate
dehydrogenase complex. Fatty acid-derived or glucose-derived acetyl-CoA enters into
the Krebs cycle, which produces reduced equivalents that are used by the electron
transport chain to produce ATP. (Adapted from Dyck & Lopaschuk, 2002).
For abbreviations see Abbreviations list.
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2.3 Insulin Signaling
Insulin affects many biological responses in cells like gene expression as well as
cellular metabolism (Lee & Pilch, 1994). In the heart, insulin has direct effects on both
glucose transport, glycolysis (Depre et al, 1998), glucose oxidation and glycogen
synthesis (Belke et al, 2001). Insulin may also increase cardiac contractility (Ren et
al, 2000) and has an anti-apoptotic effect on cardiomyocytes (Aikawa et al, 2000).
In order to affect cellular processes, insulin binds to specific insulin receptors on the
cell surface, which are receptor tyrosine kinases composed of an external a.-dimeric
subunit and an internal J3-dimeric subunit (Shepherd et al, 1998) (see Figure 2.3).
When insulin binds to the a.-subunit, the J3-subunit auto-phosphorylates (White &
Kahn, 1994). This autophosphorylation amplifies the effect of insulin and also
stimulates an intrinsic receptor tyrosine kinase activity, which results in multi-site
phosphorylation of the cytosolic insulin receptor substrate proteins (IRS-1, 2, 3 and 4)
(Shepherd et a/ 1998; De Luca et a/1999; Wang et al, 1999). The major IRS protein
in the heart is IRS-1.
16
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Figure 2.3. A schematic model of the IRS-1 signaling pathways mediated
through activation of the insulin receptor kinase and phosphorylation of IRS-1
or Shc. Shc contains a PTe (phosphotyrosine binding) domain, and when
phosphorylated, activates the MAPKinase pathway. (Adapted from White &
Kahn, 1994and Holmanand Kasuga 1997)
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IRS-1 in turn acts as a docking site for several proteins through its multiple tyrosine
phosphorylation sites for proteins containing Src-homology 2 (SH2) recognition
motifs. These phosphorylated sites act as binding domains, thus alerting signaling
pathways to increase the activity of many crucial enzymes by phosphorylating them
(White & Kahn, 1994). Three of these crucial enzymes are glycogen synthase, the
rate limiting enzyme in glycogen storage (De Luca et aI, 1999), pyruvate
dehydrogenase (Opie, 1998) and phosphatidylinositol 3-kinase (PI3-K) (De Luca et
al, 1999; Kirwin et al, 2000).
2.3.1 Pl3-Kinase (PI3-K)
Activation of the insulin-receptor tyrosine kinase results in the rapid recruitment of
phosphoinositide 3-0H-kinase (PI3-K) activity into signaling complexes, and current
evidence indicates that class 1a PI3-K accounts for the majority of this increase
(Shepherd et aI, 1998). PI3-K enzymes are a family of lipid kinases present in all cell
types and are characterized by their ability to phosphorylate the 3-0H position of the
inositol ring of several different phosphoinositides (Duronio et aI, 1998). PI3-K is a
heterodimer composed of an 85kDa (p85) regulatory subunit and an 110kDa (p110)
catalytic subunit (Kohn et aI, 1996). The p85 subunit binds to other molecules via its
Src-homology 2 (SH2) domain such as the tyrosine residues of the IRS-1, p110,
phospholipase C (PLC), Ras GTPase-activating protein and others (White & Kahn,
1994). The p110 subunit phosphorylates the cellular lipids phosphatidylinositol mono-
or bisphosphate (PIP or PIP2) at the 3' position of the inositol rings (Meyers et aI,
18
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1994; De Luca et aI, 1999), producing Ptdlns(3,4)P2 , Ptdlns(3)P and Ptdlns(3,4,5)P3.
G-protein regulated class 1b-PI3-K associates with a family of adapter subunits
unrelated to those of class 1a-PI3-K, and there is no evidence that they are activated
by insulin (Stephens et aI, 1997). Although class 2 PI3-Ks are widely expressed and
are activated by insulin, they seem unlikely to play a role in mediating any of the
common insulin responses since they cannot use PI(4,5)P2 as a substrate to produce
PIP3 (which is thought to be a key mediator in insulin signaling) and they are
relatively resistant to the P13-K inhibitors, while many insulin responses are very
sensitive to these inhibitors (Domin et aI, 1996).
The fungal inhibitor wortmannin has been shown to be a potent inhibitor of 1a (Ui et
al, 1995), 1b (Stoyanova et al, 1997) and class 3 (Volinia et al, 1997) PI3-K activity
(Powis et aI, 1994). LY294002 is another highly specific inhibitor of class 1 PI3-Ks,
although class 2 PI3-Ks are relatively resistant to this inhibitor (Domin et aI, 1997).
Lipid products of PI3-K act as signaling molecules. PIP3 is the main product of class
1a PI3-K and can directly modulate downstream events by specifically interacting
with molecules in downstream signal transduction pathways:
i) by acting in an allosteric manner they may alter the catalytic activity of targets;
ii) by changing conformation the interactions may expose regulatory sites for
phosphorylation, and iii) interactions may regulate co-localization with other PIP3 -
binding proteins to form specific signaling complexes at membranes (Shepherd et aI,
1997). It acts to recruit pleckstrin-homology (PH)-domain-containing proteins such as
19
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phosphatidylinositol-dependent protein kinases (PDKs) as well as protein kinase B
(PKB/Akt) (Marte & Downward, 1997) to the cell membrane.
Evidence is emerging which suggests that PI3-K also plays a crucial role in activation
of certain isoforms of protein kinase C (PKC epsilon) (Yatomi et al, 1992, Moriya et
al, 1996, Shepherd et al, 1998).
The jun-N-terminal kinase (JNK) also lies downstream of PI3-K, as demonstrated by
the findings that PI3-K activity is necessary for the growth factor stimulated activation
of JNK (Lopez-lIasaca et ai, 1997) It is suggested that the activation pathway in this
case involves the small GTP-binding proteins Rae or cdc42 as these lie upstream of
JNK and the activation of Rae is PI3-K dependent (Coso et ai, 1995, Hawkins et ai,
1995).
2.3.2 Protein Kinase B (PKB/Akt)
The origins of PKB/Akt research can be traced back to the discovery of a
transforming murine leukemia virus from mice with a high incidence of spontaneous
lymphoma, by Staal and co-workers in 1977. This virus was termed AKT8 and had
the ability to induce focus formation in other cell lines which suggested that the virus
contained a previously undescribed oncogene. Staal and co-workers isolated and
termed this oncogenic sequence akt (Staal et ai, 1988). Human homologues AKT1
and AKT2 were also identified in gastric carcinomas and this supported the
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hypothesis that this akt gene played a strong role in the pathogenesis of human
malignancy and tumor formation (Staal et aI, 1988).
In 1991 three independent research groups identified genes related to akt. Firstly,
Jones et al identified a serine-threonine protein kinase, which they termed Rac
(related to the A and C kinases), subsequently renamed PKBalAkt1. Secondly
Bellacosa et al described the similarity between v-Akt and protein kinase C. Lastly
Coffer and Woodgett (1991) used PCR to identify a novel cDNA with significant
homology to protein kinase C and protein kinase A, termed protein kinase B (PKB).
Together with the discovery of a second form, PKB~/Akt2 (Jones et aI, 1991b), these
papers established PKB/Akt as a novel phospho-protein kinase that was widely
expressed , and paved the way for future research into its diverse cellular processes
(Brazil & Hemmings, 2001).
Metabolic functions of PKB/Akt are diverse and include cellular functions such as
regulation of glucose uptake and metabolism (Kohn et aI, 1996), transcription,
apoptosis, proliferation, migration, angiogenesis (Brazil & Hemmings, 2001),
differentiation, inhibition of apoptosis, regulation of growth and cytoskeleton
organisation (Duronio et al, 1998).
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2.3.2.1 Structure of PKB/Akt
PKB/Akt has been described as a novel phospho-protein kinase that is widely
expressed (Coffer & Woodgett, 1991). Three main isoforms have been identified in
mammalian cells: PKBaJAkt1, PKBp/Akt2 and PKBy/Akt3. PKBaJAkt1 and PKBp/Akt2
are widely expressed, with highest levels present in the brain, thymus, heart and
lungs (Coffer & Woodgett, 1991). PKBy/Akt3 is also expressed in the heart (Patrucco
et aI, 2004). Akt1, -2 and -3 are all expressed in both normal and tumor tissue of the
lung, breast, prostate and colon, according to Zinda et al (2001). All tissues contain at
least one form of PKB/Akt. (Coffer & Woodgett, 1998).
All three iso-forms of PKB/Akt contains a serinel threonine kinase domain, as well as
a pleckstrin-homology (PH) domain at its amino-terminal end and the integrity of this
PH domain has been found to be crucial for activation of PKB/Akt in intact cells in
response to PI3-K activation (Klippel et aI, 1996). Alessi and colleagues in 1996
identified 4 sites on PKB/Akt that are phosphorylated in vivo. Thr-308 and Ser-473
are inducibly phosphorylated by extracellular stimuli, whereas Ser-124 and Thr-450
appear to be basally phosphorylated.
PKB/Akt is an important mediator of the physiological effects of insulin and is a target
for PI3-K (Marte & Downward, 1997).
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2.3.2.2 Activation of PKB/Akt
PKB/Akt has been shown to be activated by a wide variety of stimuli including
cytokines, chemokines (Tilton et aI, 1997), heat shock, hypoxia, integrins and growth
factors (Andjelkovic et al, 1998).
PI3-K activation results in the production of Ptdlns(3,4,5)P3 and Ptdlns(3,4)P2. There
is an essential role for the PH domain and binding of PIP2 and PIP3 in the activation
and regulation of PKB/Akt (Klippel et aI, 1997). Interaction of the PH domain of
PKB/Akt with these lipids might cause it to translocate to the plasma membrane,
which could be where the stimulating kinases are active. It could also promote
conformational changes which would lead to enhanced phosphorylation by upstream
kinases (Marte & Downward, 1997) (see Fig 2.4).
The assembly of the phosphoinositide-dependant protein kinases (PDKs) and
PKB/Akt at the same site allows PKB/Akt to become phosphorylated at two residues.
PDK-1 phosphorylates PKB/Akt at threonine-308 and PDK-2 phosphorylates PKB/Akt
at serine-473. Phosphorylation of both is required for full activation of the kinase.
(Alessi et al, 1996; Coffer et al, 1998).
PDK-1 is insensitive to wortmannin (Marte & Downward 1997), but PDK-2 is sensitive
to wortmannin, suggesting that it is under the control of PI3-K (Alessi et aI, 1996).
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Figure 2.4 A model for PKB activation and downstream events (modified from
Coffer et al, 1998)
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2.3.2.3 Regulation of PKB/Akt
Regulation of PKB/Akt activity is of the utmost importance since constitutively active
PKB/Akt has been shown to cause oncogenic transformation of cells (Mirza et ai,
2000), and PKB/Akt isoforrns have been shown to be overexpressed in breast cancer
cell lines (Jones et ai, 1991b), as well as ovarian (Cheng et ai, 1992) and pancreatic
(Cheng et aI, 1996) cancers and gastric adenoma (Staal et ai, 1987). On the other
hand, dominant negative PKB/Akt cell lines show increased apoptosis in infected
cells (Esfandiarei et al, 2004; Kim et al, 2004).
PTEN (phosphatase and tensin homologue deleted on chromosome ten), a novel
tumour suppressor protein involved in PKB/Akt regulation, appears to control the
activity of PKB/Akt by limiting the lipid substrate Ptdlns(3,4,5)P3 necessary for its
activation (Brazil and Hemmings, 2001) by dephosphorylating it. Conversely,
inactivation of PTEN could have significant implications for the activation state of
PKB/Akt, for example Leslie et al showed in 2003 that oxidative stress activated P13-
K-dependent signaling via the inactivation of PTEN. It has been shown that
mutations in PTEN that inactivate this lipid phosphatase function allow unregulated
PKB/Akt activity and uncontrolled cell proliferation (Myers et ai, 1998). Since PKB/Akt
has been widely implicated in tumor genesis (Bao et aI, 2004) PTEN (Hlobilkova et
ai, 2003), as well as PKB/Akt (Hanada et ai, 2004) are thus potential targets for
cancer therapy.
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There are survival stimuli that activate PKB/Akt via mechanisms independent of P13-
K activation (Datta et ai, 1999). Agonists of the PKA pathway can activate PKB
. (Sable et ai, 1997) as can agents which raise intracellular calcium levels (Tilton et ai,
1997). Calcium binds to calmodulin and the Ca2+/calmodulin complex activates the
calcium/calmodulin dependent kinase (CaMK), which then activates PKB/Akt by
direct phosphorylation of Thr-308 (Yano et ai, 1998).
Since PI3-K can also be stimulated by direct interaction with the Ras proto-oncogene
GTPase Ras, PKB/Akt is also controlled by Ras. Activated Ras will stimulate PKB/Akt
(Datta et al, 1996; 1999).
Cellular stresses such as heat shock and hyperosmolarity, both of which can
stimulate the activity of p38/HOG1 kinase cascade, can stimulate the activity of
PKB/Akt. Heat shock induces association of PKC with the PH8 domain of PKB/Akt.
Integrin-linked kinase (ILK), a serine threonine kinase that interacts with the
cytoplasmic tail of integrin f3 subunits (Delcommenne et ai, 1998) has also been
suggested to regulate PKB/Akt by phosphorylation at Ser-473. ILK is directly
regulated by PI(3,4,5)P3, presumably through binding of lipids to a PH domain within
ILK, however further studies are necessary to determine whether ILK activity alone is
sufficient to activate PKB/Akt in vitro.
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Since PKB/Akt is a downstream target of PI3-K, its action is also blocked by the
inhibitor wortmannin (Ng et al, 2001).
2.3.2.4 Targets of PKB/Akt
One of the first important downstream target kinases that appears to be regulated by
activities of PI3-K and PKB/Akt is glycogen synthase kinase 3 (GSK-3) (Marte and
Downward, 1997). PKB/Akt was found to phosphorylate and inactivate GSK-3, which
in tum regulates a number of substrates involved in cellular metabolism, including
glycogen synthase (Cross et ai, 1995).
PI3-K and PKB/Akt are well known as pro-survival factors, and one of the routes by
which this is accomplished, is by the phosphorylation of an early downstream target
identified as the pro-apoptotic factor BAD. This was shown to be phosphorylated on
residue Ser-136 by PKB/Akt, and this phosphorylation, stimulated by ligands such as
IGF-1, prevented BAD-induced cell death (Datta et ai, 1997; del Pesto et ai, 1997).
In Table 1 the complete list of PKB/Akt substrates can be seen. This includes the
aforementioned BAD phosphorylation and GSK-3 inhibition. Included too are the
phosphorylation and activation of eNOS to produce NO, the activation of
phosphofructokinase (PFK2) to increase glycolysis, and the activation of mammalian
target of rapamycin (mTOR).
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Table 1. Current list of published protein kinase B (PKB)/Akt substrates
(modified from Brazil and Hemmings,2001).
Protein Effect of phosphorylation
BAD blocksBAD-inducedapoptosis
C-Raf inhibitsC-Raf activity
B-Raf inhibitsB-Raf activity
BRCA-1 interfereswith nuclear localizationof BRCA-1
CREB increasedassociationwith CBP and pl30
eNOS activateseNOSand leads to NO production
FKHRL1 inhibits transcriptionalactivity of FKHRL1
GSK-3a. inhibitsGSK-3 activity
GSK-3J3 inhibitsGSK-3 activity
I-KB-kinasea. activates transcriptionalactivityof NF-KB
IRS-1 protects IRS-1 from the activity of PYPase
mTOR activatesmTORactivity
POE3B inactivatesPDE-3B
PFK-2 activates PFK-2
Rac1 inhibits Rac1-GTPbinding
hTERT enhancestelomeraseactivity
p21CIP1 causes cytoplasmic localizationof p21CIP1
Nur77 inhibits transcriptionalactivity of Nur??
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2.3.2.5 PKB/Akt and Glucose Uptake
The final step in the preparation process for glucose uptake is the fusion of GLUT4-
containing vesicles with the plasma membrane (Foster and Klip, 2000). Work by
Tanti et al in 1997 with adipocytes suggests a direct link between PKB/Akt activation
and GLUT4 translocation to the membrane. There is additional evidence that
PKB/Akt interacts with the GLUT4 containing vesicles in the cell cytosol, and causes
these vesicles to translocate to the cell surface and deposit their contents in the cell
membrane in muscle cells (Wang et ai, 1999b) and adipose cells (Cong et ai, 1997;
Calera et al, 1998).
2.3.2.6 Caveolae
Insulin receptor signal transduction has been demonstrated to depend on functional
caveolae (Karlsson et ai, 2001). Caveolae are small flask-shaped invaginations of the
plasma membrane expressed in most terminally differentiated mammalian cell types
(Shaul and Anderson, 1998). They are related to raft microdomains, and enriched in
sphingolipids and cholesterol. They appear to form lipid rafts in the presence of the
principal structural protein caveolin, which serves as their marker. These specialized
microdomains are common in endothelial, muscle, and adipose tissues and appear to
be involved in uptake of solutes into the cytosol and in signal transduction (Smart el
aI, 1999). Karlsson et al (2001) showed that GLUT4 in the plasma membrane is
largely located in the caveolae in response to insulin stimulation.
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2.4 Contraction and Exercise
The rate of glucose uptake is subject to the influence of three states: rest, physical
activity (including the effects of hypoxia) and alimentation (including effects of fat and
plasma free fatty acid (FFA) concentration) (ZierIer 1999).
Acute exercise, similar to insulin, increases the uptake of glucose into muscle (Douen
et aI, 1990). Exercise, or muscle contractions, can increase the rate of glucose
uptake into the cell 10 to 20 fold and this occurs despite a decrease in insulin
concentrations (Wahren et aI, 1971), thus via a mechanism that is independent of
insulin (Holloszy, 2003).
In 1979 Soman et al showed that acute exercise led to a significant increase in
insulin binding to monocytes, which retumed to basal 24 hours after exercise.
Spontaneously exercised rats show enhanced responsiveness to exogenous insulin
at rest in the research of Mondon et al in 1980, while Koivisto et al, 1980, reported
that, in previously untrained subjects, physical training resulted in a 35% rise in
insulin binding to monocytes. Kirwan et al (2000) found that there was enhanced
insulin sensitivity in skeletal muscle associated with exercise training.
The heart has a greater oxygen consumption both at rest and during exercise
compared to skeletal muscle (Rowell, 1986). Kemppainen et al (2002) showed that
during low- and moderate- intensity exercise, myocardial glucose uptake doubled as
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compared to the resting state. This has been shown to be brought about by an
increase in the number of glucose transporters (GLUT4) in the plasma membrane
(Douen et aI, 1989, Fushiki et aI, 1989). Although the cardioprotective effects of
exercise have been widely shown (Davidoff et aI, 2004; Vona et aI, 2004), it is
currently unknown whether exercise will enhance cardiac insulin sensitivity.
However, if the intensity of the exercise is increased to a very high level, myocardial
glucose uptake is lower than it is during lower intensity levels (Kemppainen et aI,
2002). This indicates that during higher intensity levels the increased myocardial
energy needs are provided for by substrates other than glucose.
The effects of exercise on glucose uptake have been shown to be additive to that of
insulin (Koval et aI, 1999; Kirwin et aI, 2000). This finding strongly suggests that
different biochemical pathways are involved in the effects of exercisel contraction and
insulin on glucose uptake.
Oxygen deprivation, which occurs in the muscle during exercise, induces a rapid
stimulation of glycolysis, known as the Pasteur Effect (Randle and Morgan, 1962).
This effect is brought about by activation of PFK-1 (phospho-fructo-kinase 1) due to
the increase in the AMP:ATP ratio that occurs under these conditions. It has been
shown that this effect is mediated by AMPK.
31
Stellenbosch University http://scholar.sun.ac.za
2.5 AMP-activated protein kinase (AMPK)
2.5.1 Structure of AMPK
AMPK is a heterotrimeric enzyme composed of a catalytic (a.) subunit and two
regulatory (p and y) subunits (Hardie et ai, 1998). Each subunit exists as alternate
isoforms encoded by two or three genes (0.1, 0.2, 131,132,y1, y2, y3) and all twelve
different combinations of isoforms appear able to form complexes (Hardie, 2003).
The predominant isoforms in most cells are 0.1, 131and y1 and skeletal and cardiac
muscle also expresses 0.2, 132,y2 and y3 (Stapleton et ai, 1996; Kemp et ai, 1999).
The core of the 13subunit contains a conserved domain that has recently been
recognized as a glycogen-binding domain (GSD) (Hudson et ai, 2003; Polekhina et
al,2003).
2.5.2 Activation and regulation of AMPK
AMPK is activated by any stress treatment that interferes with ATP production where
the ratio of AMP: ATP in the cell increases due to nutrient or exercise induced stress
(Hardie and Hawley, 2001; Hardie 2003). Stresses include heat shock (Corton et ai,
1994) metabolie poisons (Corton et al, 1994) glucose deprivation (Salt et al, 1998)
and hypoxia and ischaemia in heart muscle (Kudo et aI, 1995). These are all
abnormal, pathological occurrences which decrease ATP production, but AMPK can
also be activated by a physiological stress such as increased ATP consumption
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induced by exercise (Winder and Hardie, 1996; Fujii et aI, 2000). AMPK is activated
by exercise or contraction in rodent (Winder and Hardie 1996) and human (Fujii et aI,
2000) muscle, with activation being dependent on the duration as well as the
intensity of the exercise (Stephens et aI, 2002).
AMPK is allosterically activated by AMP, but also by phosphorylation by one or more
upstream kinases, termed AMPK kinases (recently identified as LKB1 (Hawley et aI,
2003 and Woods et aI, 2003)) at threonine residue 172 within the "activation loop" of
the ct subunit kinase domain. Without this phosphorylation there is no detectable
activity of AMPK (Hawley et aI, 1996; Stein et aI, 2000). LKB1's activation is also
promoted by increased AMP levels (Weekes et aI, 1994).
AMPK is allosterically inhibited by physiological concentrations of phosphocreatine
(Ponticos et aI, 1998) and this confirms the proposed physiological role of AMPK as a
sensor of cellular energy status.
2.5.3 Role of AMPK
AMPK plays a key role in maintaining energy homeostasis in the cell (Hardie et aI,
1998) since it is sensitive to AMP levels within the cell and is activated by a rising
AMP/ATP ratio, indicative of energy depletion. It acts as an energy sensor in the cell
because it recognizes ATP depletion (Hardie and Carling, 1997) and prevents any
further ATP utilization by anabolic pathways, but also initiates changes to restore
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cellular ATP levels (Kemp et aI, 1999). Activated AMPK phosphorylates and
inactivates key enzymes involved in ATP-utilizing pathways e.g. enzymes involved in
glycogen, fatty acid and cholesterol synthesis, and stimulates enzymes controlling
catabolism. In the heart and skeletal muscle AMPK plays an important role in
accelerating fatty acid oxidation, glucose uptake, GLUT4 translocation, glycolysis,
FAT/CD36 translocation and fatty acid uptake (Hardie and Hawley, 2001).
The AMPK signaling pathway provides an alternative to the insulin-dependant
glucose uptake pathway in muscle. Resistance of muscle to the effects of insulin is
one of the first defects leading to the development of type II diabetes mellitus. This
reduction in insulin sensitivity is reflected in decreased insulin-stimulated glucose
uptake (Fryer et aI, 2000). Since AMPK activates glucose uptake via a distinctly
different pathway to insulin, this AMPK path may present the perfect mechanism to
manipulate pharmacologically to treat this disease. AMPK has also been found to be
activated in the muscle of subjects with type II diabetes during exercise (Musi et aI,
2001).
If activation of AMPK mediates the metabolic effects of exercise, and exercise
sensitizes muscle to the effects of insulin, the biochemical pathway that results in
AMPK activation, must cross-talk with the biochemical pathway that is activated by
insulin.
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Indeed, in insulin-resistant humans and rodents, regular exercise enhances insulin
sensitivity (Seals et al, 1984; Trovati et al, 1984; Rogers et al, 1988; Cortez et al,
1991; Dela et al, 1992; Hughes et al, 1993; Houmard et al, 1999; Chibalin et al,
2000). Importantly, insulin-stimulated Pl3-kinase activity is greater in skeletal muscle
from young healthy individuals who do regular exercise compared to sedentary
individuals (Kirwin et aI, 2000). Therefore, enhanced insulin action after exercise may
be due to improvements in insulin signal transduction (Kemppainen et at, 2003).
In 2001, Musi and coworkers were the first to demonstrate that an acute bout of
exercise led to a significant increase in AMPKa.2 activity in the skeletal muscle of
individuals with type 2 diabetes. This finding supported the idea put forward by
researchers (e.g. Winder 2000) that increasing glucose uptake by the muscle through
pharmacological manipulation of AMPK (e.g. AICAR) could be an important strategy
for the treatment of type 2 diabetes.
2.5.4 Targets of AMPK
As seen in Figure 2.5, AMPK has many targets and thus effects several physiological
pathways.
2.5.4.1 Acetvl-CoA carboxylase
AMPK is involved in the regulation of acetyl-CoA carboxylase (ACC), the enzyme that
catalyses malonyl-CoA synthesis (Kudo et al, 1995; Kemp et al, 1999; Saha et al,
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2000). AMPK inhibits this enzyme by phosphorylating it, and thereby reduces the
level of malonyl CoA. Malonyl CoA is an inhibitor of camitine palmitoyl-transferse I
(CPT1) (Saha et ai, 2000) which is located on the outer surface of the mitochondrion
and is responsible for the transport of long-chain fatty acids into the mitochondrion
with camitine for oxidation (Kemp et ai, 1999). Therefore by increasing AMPK
activation, fatty acid intake into the mitochondrion is increased and oxidation occurs.
Decreases in malonyl-CoA concentration in muscle during exercise have been linked
to decreases in ACC activity (Vawas et ai, 1997; Saha et ai, 2000) as have
increases in ACC phosphorylation been linked to increases in AMPKa.2 activity
(Stephens et al, 2002).
2.5.4.2 HMG-CoA Reductase
Through an acute, rapid effect of AMPK, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)
reductase activity is decreased and so too is sterol synthesis (Corton et ai, 1994).
2.5.4.3 Creatine Kinase
The creatine kinase (CK)-phosphocreatine system plays a crucial role in the
maintenance of ATP levels in tissues that have a high and fluctuating energy
requirement. CK catalyses the interconversion of creatine (Cr) and ATP with
phospho-creatine (PCr) and ADP (Walliman, 1994). Thus CK is presumed a prime
target for AMPK action, and Ponticos et al demonstrated in 1998 that AMPK
phosphorylates and inactivates the muscle specific isoform of CK (MM-CK). They
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also demonstrated that not only was AMPK activity regulated by the ATP:AMP ratio,
but by the PCr:Cr ratio as well.
2.5.4.4 Glycogen Synthase
Glycogen synthase is also phosphorylated and thereby inactivated by AMPK. Thus
the synthesis of glycogen is halted (Carling and Hardie, 1989).
2.5.4.5 Glucose Uptake
The work of Hayashi et al (1998) also suggested that AMPK stimulates glucose
uptake. These studies, involving exercise stimulated glucose transport as well as
stimulation of AMPK with 5-aminoimidazole-4-carboxamide-1-p-D-ribonucleoside
(AICAR), show enhanced glucose uptake via an insulin independent pathway and will
be discussed in Chapter 2.6 as it has specific relevance to the current study.
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Figure 2.5 Physiological targets and pathways regulated by AMPK (from Hardie
2003).
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2.6. 5' -aminoimidazole-4-carboxamide-1-f3-D-ribonucleoside (AICAR)
AICAR is an adenosine analogue which is taken up into cells and converted to the
monophosphorylated nucleotide, 5-aminoimidazole-4-carboxamide-ribonucleoside
monophosphate (ZMP), by adenosine kinase (Sabina et ai, 1985; Hardie 2003). It
was described as a specific activator of AMPK (Carton et ai, 1995) in intact cells. It
has also been found that ZMP, an analogue of AMP, mimics the effect of AMP on
allosteric activation of AMPK (Sullivan et ai, 1994) and promotion of phosphorylation
and activation of AMPK by LKB 1 (Weekes et ai, 1994).
It is important to note that stimulation with AICAR does not change the ATP/ADP or
ATP/AMP ratios in the cells (Carton et ai, 1995), which indicates that the conversion
of ZMP to AMP is slow.
There are numerous studies showing that AICAR increases AMPK phosphorylation
as well as glucose uptake in skeletal muscle. The latter was shown to be mediated by
increased GLUT4 translocation (Lochhead et ai, 2000; Ojuka et ai, 2000; Buhl et ai,
2001).
However, the matter of AMPK activation by AICAR is still controversial. A few studies
have shown no increased AICAR-induced AMPK activity or glucose uptake in a
diversity of tissues. For example Kaushik et al (2001) as well as Balon and Jasman
(2001) showed that AICAR exposure did not stimulate glucose uptake in rat soleus
muscle. On the other hand, convincing evidence has been presented for the
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stimulation of glucose uptake in skeletal muscle by AICAR. AMPK activation by
AICAR in the rat lateral and medial gastrocnemius led to increased glucose uptake
(Bergeron et aI, 1999). Similarly, work by Balon and Jasman also showed. dramatic
increases in glucose uptake in isolated mouse soleus muscle incubated with 2 mM
AICAR (Balon and Jasman, 2001).
Exposure of rat epitrochlearis muscles to 0.5 mM AICAR activated AMPK and
increased GLUT4 translocation (Ojuka et aI, 2000), while chronic treatment with
AICAR (1mg/g body wt subcutaneous injection per day for 5 days) increased insulin-
stimulated glucose uptake and GLUT4 translocation in rat gastrocnemius muscle
(Buhl et aI, 2001). However in this same study by Buhl et al they showed no increase
in these parameters in white twitch soleus muscle.
There is, however, only one study to date published on the effects of AICAR on the
uptake of glucose in the heart. Russell et al showed in 1999 that AICAR increased
glucose uptake in isolated rat ventricular papillary muscles.
Although there is evidence for the stimulation of glycogenolysis by AICAR in the heart
(Longnus et aI, 2003), it had no effect on glycolysis in rabbit cardiomyocytes (Javaux
et aI, 1995) which led to the theory that the effect of AICAR is dependent on the
capacity of the cells to accumulate ZMP and the presence of target enzymes which
are sensitive to ZMP (Javaux et aI, 1995).
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There have also been studies where it was found that treatment of cells with the
combination of AlGAR and insulin led to enhancement of the insulin signaling
pathway as well as enhancement of insulin-stimulated glucose uptake (Buhl et aI,
2001; Jessen et aI, 2002). It was seen that chronic AlGAR administration and long-
term exercise both improved insulin-stimulated glucose uptake in skeletal muscle in a
fiber type specific way with the most marked increase in muscles with high content of
type II fibres, and this was associated with an increase in GLUT4 content (Jessen et
aI, 2002). Buhl et aI, (2001) showed that rats subcutaneously injected with AlGAR
had a marked increase in maximally insulin-stimulated glucose uptake in
epitrochlearis and extensor digitorum longus muscles, but not in soleus muscles.
Similarly, combining insulin and AlGAR led to a fully additive effect on glucose uptake
in the epitrochlearis muscle according to Bergeron et al (1999). Furthermore, AlGAR
treatment improved glucose homeostasis in insulin resistant (ob/ob) mice in skeletal
muscle and liver (Song et aI, 2002).
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In view of the above we hypothesized that stimulation of the heart with AICAR or
ZMP would lead to a sensitization of the heart muscle for insulin stimulation, and we
therefore aimed to determine:
i) Whether AICAR can activate AMPK in heart muscle
ii) Whether this pharmacological activation will mimic some of the
physiological effects of exercise e.g. increased glucose uptake and GLUT4
translocation
iii) Whether AICAR, in any way, affects the biochemical pathway activated by
insulin and leading to glucose uptake.
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CHAPTER3
MATERIALS AND METHODS
3.1 Animals
Male Wistar rats weighing between 250-350g were used in all experiments. The
rats were allowed free access to food (standard rat chow) and water, and
maintained in animal quarters at 22°C with a 12 hour day/night cycle. Animals
were anaesthetised with an intraperitoneal injection of pentobarbitone sodium at a
concentration of 0.12mg/gram. The project was approved by the Ethics committee
of the Faculty of Health Sciences, University of Stellenbosch.
3.2 Materials
Materials purchased from Sigma
2-3,butane-dione monoxime (BDM), HEPES hemisodium salt technical grade
minimum 99.5% titration, pyruvate, mercaptoethanol, N,N,N',N'-
tetramethylethylenediamine (TEMED), ponceau S, phenylmethylsulphonyl fluoride
(PMSF), Na-p-nitrophenylphosphate (p-NPP), 5-aminoimidazole-4-carboxamide-
1-~-D-ribofuranoside (AICAR), 5'-aminoimidazole-4-carboxamide-ribonucleoside-
phosphate (ZMP), wortmannin, insulin, triton-X-100, benzamidine, 8-cyclopentyl-
1,3-dipropylxanthine (8-CPT).
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Materials purchased from Merck NT laboratory supplies (Pty). lTD [Darmstadt.
Germany]
d-glucose, sodium dodecyl sulphate (SOS), ammonium peroxodisulphate (APS),
tris(hydroxylmethyl) aminomethane, trypan blue, (Analar grade).
Materials purchased from Worthington
type 2 collagenase.
Materials purchased from Roche Diagnostics
bovine serum albumin (BSA), fraction V, fatty acid-free.
Materials purchased from Millipore, UK.
Millipore immobilon-p polyvinylidene fluoride (PVDF) microporous membrane.
Materials purchased from Fluka
acrylamide
Materials purchased from Amersham Biosciences, UK Ltd
ECl Western blotting detection reagents, anti-rabbit 19, horseradish peroxidase
linked whole secondary antibody
Materials purchased from PerkinElmer Lifesciences, Boston
2-deoxy-D-[3H]g lucose
Materials purchased from Santa Cruz Biotechnology Inc.
GlUT4 (H-61): sc-7938 rabbit polyclonal antibody
Materials purchased from Cell Signaling technology
p38 MAP Kinase Antibody, phospho-PKB/Akt (Ser473) antibody, phospho-AMPK-
a (Thr172) antibody
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3.3 Isolation of cardiomyocytes
Rod-shaped ventricular cardiomyocytes from male Wistar rats were obtained by
the method as described by Fischer et al (1991). Hearts were quickly removed
from anaesthetised animals and immediately mounted on a perfusion rig via the
aorta. Hearts were perfused by the method of Langendorff retrogradely with
medium A (see addendum) nominally calcium-free, pH 7.4, 37°C, equilibrated with
95% 02 / 5% C02, for 5 minutes in order to remove the blood from the coronary
vessels. The perfusion was then switched to oxygenated medium B (see
addendum) at 37°C, and perfused in a recirculating manner. After 15 minutes
CaCb was added to the medium to raise the calcium concentration to 100 J..lM;
after 5 more minutes, the calcium concentration was raised to 200 J..lM.The
calcium concentration was risen to physiological concentrations in a stepwise
manner in order to create the minimum amount of stress for the cardiomyocytes
and to prevent them from going into calcium overload.
Perfusion was continued to a total of 35 minutes; the heart was then cut off the
catheter, carefully torn open and the incompletely digested tissue then gently
minced with tweezers. The tissue was subsequently incubated in a shaking water
bath (37°C, 60 strokes/min, 5cm/stroke) for 20 minutes in a mixture consisting of
one part medium B and one part medium C (see addendum) under an oxygen
atmosphere. During the last 5 minutes of incubation, the calcium concentration
was raised in a stepwise manner to 1.25 mM.
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After digestion the suspension was filtered through a nylon net (mesh size 200 x
200 urn) and gently spun down (10 x g, 3 min). The supernatant was rapidly
aspirated and the loose pellet resuspended in medium 0 (see addendum) at room
temperature. The cells were left to sediment for no more than 5 minutes, the
supernatant was removed and the loose pellet resuspended in 15 ml medium D.
The myocyte suspension was then kept in a slowly rotating, closed vial under an
oxygen atmosphere at room temperature for at least 1 hour to allow recovery from
the isolation procedure. Before the beginning of the experiments, the
cardiomyocytes were washed three times with assay buffer, medium E (see
addendum).
3.4 Cell viability
Osmotic fragility coupled to trypan blue exclusion (TBE) and cell morphology were
used as indices for assessment of cell viability. (Adapted from Armstrong et aI,
1994)
Approximately 12.5J.l1(representing 80 000-100 000 myocytes) of the myocyte cell
pellet was removed after the hour of incubation at room temperature, washed with
medium 0, and resuspended for 3-5minutes in 100J.l1of hypotonic medium D.
Thereafter the suspension was further diluted (1: 1) with counting medium (see
addendum). 10 J.l1 of the final counting suspension was placed on a
haemocytometer counting slide and examined light microscopically (1OOx
magnification) to evaluate the absorption (non-viable) or exclusion (viable) of
trypan blue dye. Blue cells were counted as non-viable as their membrane
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integrity had been compromised leading to uptake of the blue dye. Yellow cells
were counted as viable.
Time zero viability (viable cells calculated as a percentage of the total cells in a
sample) varied between 70% and 80% and all cell isolates of less than 70%
viability were discarded.
The use of myocyte morphology as an index of viability involved the same
procedure as above, with the exception that the cells were suspended in an
isotonic medium D and counting medium. Rod-shaped cells (length: width ratio ~
3:1) were considered viable whereas square-shaped (length: width ratio s 3:1)
and round cells were considered non-viable. Cell viability was expressed as the
percentage rod-shaped cells present.
(Armstrong and Ganote, 1991)
3.5 Detection of Glucose Uptake
Myocyte uptake of 2-deoxy-D-[3H]glucose (2DG) was measured in assay medium
E, pH 7.4, 3JOC, equilibrated with oxygen.
O.Sml of washed cell suspension (corresponding to approximately 1.Smg cell
protein) was assayed in a total volume of 7S0f..l1of medium E with or without an
appropriate dilution for one or several agents to be tested. Cells were incubated in
flat-bottomed vials, at 3JOC under an oxygen atmosphere in a shaking water bath
(60 strokes/min, Scm/stroke). 2DG accumulation in these cells was measured in
the presence or absence of 400f..lMphloretin as described by Fischer et al (1991).
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Phloretin at this concentration totally blocks glucose uptake by GLUT4 and
GLUT1, therefore carrier mediated glucose uptake. Myocyte glucose uptake in the
presence of phloretin was subtracted from all values to determine carrier mediated
uptake.
The samples were incubated as indicated in Figure 2.1. After stimulation, the
myocytes were further incubated in the presence of 2DG (3JlCi/ml, final
concentration 1.5JlM) for an additional 30 minutes before 2DG uptake was
stopped by adding phloretin (to a final concentration of 400JlM). The samples
were then immediately transferred into 1.5ml eppendorf tubes, and centrifuged at
10 OOOxgfor 1minute at room temperature to separate the cells from the less
dense incubation medium. The supematants were aspirated and the pellet
washed twice with medium A, whereafter the pellet was dissolved in 0.5N NaOH.
An aliquot of this suspension was used in protein determination by the method of
Lowry et al (see chapter 3.12), while 3 x 100JlIof the rest was counted in 2ml of
scintillation fluid in a liquid scintillation counter (Beckman). Specific, i.e. glucose-
carrier-mediated 2-deoxy-D-glucose uptake was calculated by subtraction of
uptake monitored in the presence of 400JlMphloretin from values measured in the
absence thereof (Fischer et a/1991).
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Figure 3.1 Diagram of cardiomyocyte protocol for glucose uptake
AI/ groups were equilibrated for a 5minute period. Various agents were added in
the fol/owing concentrations for the times indicated: Insulin (100nM) 15 minutes,
AICAR (1mM) 30 minutes, ZMP (1mM) 30 minutes, Worlmannin (100nM) 15
minutes before either insulin or AICARI ZMP stimulation as indicated, Eq =
equilibrium. Please note that once an agent was added, it remained in the
medium until the end of the experiment.
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1. Basal 2DG uptake of the cells measured after 50 minutes incubation followed
by 30 minutes incubation with radioactively labelled 2DG.
2. Phloretin was present throughout the duration of the experiment to act as a
negative control.
3. Cells were stimulated with insulin for 15minutes before the addition of 2DG.
4. AICAR or ZMP (1mM unless otherwise indicated) were added 30minutes prior
to addition of 2DG.
5. A combination of AICAR or ZMP and insulin were staggered by addition at the
time points indicated prior to 2DG addition.
6. Wortmannin was added 15minutes before the addition of Insulin.
7. Wortmannin was added 15minutes before the addition of AICAR or ZMP.
8. Wortmannin was added 15minutes before the combination of AICAR, ZMP and
insulin.
All 2DG uptake reactions were stopped by addition of phloretin to a final
concentration of 400pM.
3.6 Whole Heart Perfusion Protocol
Hearts were quickly removed from animals (anaesthetised with 0.12 mglg body wt
of sodium pentobarbitone) and immediately perfused by the method of
Langendorff with Krebs-Henseleit bicarbonate buffer with or without 5 mM glucose
as indicated. This concentration of glucose was used because it results in minimal
basal glucose uptake, which allows for a maximal stimulatory effect of insulin to be
observed on both glucose uptake and GLUT4 translocation. The perfusion
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solution was gassed with 95% O2. 5% C02 for 20 minutes before and throughout
the experiment (see Fig 3.2).
I Control
I Equilibration Insulin 100nM
I Equilibration. I AICAR 1mM
I Equilibration. I AICAR 1mM Insulin 100nM
•o minutes •15 minutes •30 minutes •45 minutes
Figure 3.2 Diagram of whole heart perfusion protocol for Western blot
analysis.
1 Hearts used as controls were continuously perfused for 45 minutes.
After a stabilisation period, the experimental hearts were either perfused with
2 Insulin (100nM) for 15minutes,
3 AICAR (1mM) for 30 minutes or
4 AICAR (1mM) for 30 minutes and Insulin (100nM) for 15minutes
Hearts were immediately freeze-clamped with Wollenberger tongs and stored in
liquid nitrogen until further use.
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3.7 Preparation of Iysates for Western Blotting
3.7.1 Cardiomyocvte Iysates
For the measurement of AMPK, PKB/Akt and GLUT4 phosphorylation patterns,
the following procedure was followed to generate Iysates for Western Blotting
analysis.
As for 2DG uptake, 0.5 ml of washed cell suspension (corresponding to
approximately 1.5 mg cell protein) was incubated in a total volume of 750 ul of
medium E. This was done with or without an appropriate dilution for one or several
agents to be assayed, in flat-bottomed-vials, at 3rG in a shaking water bath (60
strokes/min, 5 em/stroke). Basal phosphorylation was measured on a vial where
no other agents were added. The following agents were added as indicated in
Figure 3.1 and Figure 3.3 to various samples at appropriate times for stimulation
for the times indicated:
Insulin (100 nM) 15 minutes, AlGAR (1 mM) 30 minutes, ZMP (1 mM) 30 minutes,
Wortmannin (100 nM) 15 minutes before AlGAR, ZMP or insulin.
Gardiomyocytes were stimulated as indicated in figure 3.1 and samples for
determination of PKB/Akt, AMPK and GLUT4 were removed before addition of
2DG. The samples were immediately transferred to 1.5 ml eppendort tubes and
centrifuged at 10 000 x g for 1 minute at room temperature to separate the cells
from the less dense incubation medium. After centrifugation tubes were
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immediately placed on ice. The supernatants were aspirated and the remaining
pellet sonicated for 3 cycles of 5 seconds each at maximum power in the
appropriate lysis buffer (see addendum).
These Iysates were then centrifuged at 12 000 x g at 4°C for 15 minutes to
remove any particulate matter. The Bradford Method (Chapter 3.11) was used to
determine protein content of the supernatant. It was then diluted with a 3 times
Laemmli sample buffer (see addendum), boiled for 5 minutes, and stored at -20°
for Western Blot analysis.
3.7.2 Tissue Iysates from perfused hearts
After perfusion as shown in Fig 3.2, approximately 0.2g of liquid nitrogen frozen
ventricular tissue was fully pulverised in a pre-cooled mortar and pestle at 4°C.
Pulverised tissue was then added to Servall centrifuge tubes each containing
900JlI of specific lysis buffer for either AMPK or GLUT4 extraction (see
addendum). The tissue and lysis buffer was then homogenised mechanically with
a polytron PT10 homogeniser for 2 cycles of 5 seconds each and spun down in a
microfuge to remove the particulate matter. Protein determination for each sample
was conducted using the Bradford protein determination method. Samples were
then diluted with a 3 times Laemmli sample buffer (see Addendum), boiled for 5
minutes and stored at -20° for Western blot analysis.
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Figure 3.3 Diagram of cardiomyocyte protocol for Western blot analysis
AI/ groups were equilibrated for a 5minute period. Various agents were added in
the fol/owing concentrations for the times indicated: Insulin (100nM) 15 minutes,
AICAR (1mM) 30 minutes, ZMP (1mM) 30 minutes, Worlmannin (100nM) 15
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minutes before insulin / AICARI ZMP stimulation as indicated, 8-CPT (10f.JM) 15
minutes before AICARI ZMP stimulation.
1. Basal levels of activation were measured after 45 minutes.
2. Cells were stimulated with insulin for 15minutes
3. AICAR or ZMP were added for a stimulation period of 30 mintues.
4. A combination of AICAR- or ZMP and insulin were staggered by their addition
at the time points indicated.
5. Wortmannin was added 15minutes prior to the addition of insulin
6. Wortmannin was added 15minutes prior to the addition of AICAR or ZMP
7.Wortmannin was added 15 minutes before the addition of AICAR- or ZMP and
insulin
8. 8-CPT, an adrenergic (purinergic) receptor antagonist, was added 15 minutes
before the addition of AICAR or ZMP, to establish whether the effects of these two
drugs involved the purinergic receptors at all.
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3.8 Western Blotting techniques
3.8.1 General
After boiling each sample for 5minutes, equal amounts (20-50Jlg as indicated) of
sample protein from the various fractions were separated on a 12% SDS-
polyacrylamide gel (see addendum) using the standard Bio-Rad Mini-PROTEAN
III system (Biorad, Life Science group, US).
Electrophoretically separated proteins were transferred to a PVDF (polyvinylidene
fluoride) membrane by electroblotting. After staining the membranes with
Ponceau-S red (reversible staining) for visualisation and verification of transferral
of the protein bands, membraneswere scanned with laser scanning and saved as
a record of equal loading. Membranes were then washed with TBS 0.1%Tween
(TBST). Non-specific binding sites on the membranes were blocked with 5% fat-
free milk powder in TBST for 2 hours at room temperature.
Following the blocking procedure membranes were washed thoroughly with TBST
and incubated with the appropriate primary antibody (1:1000 dilution in TBST) for
5-16 hours at 4°C. After washing the membranes with TBST, the immobilised
primary antibody was conjugated with a diluted (1:4000) horseradish peroxidase-
labelled secondary antibody for 1 hour at room temperature. The membranes
were again washed thoroughly with TBST. Bands were visualised with electro-
chemiluminescence (ECl TM) detection agents used according to the
manufacturers instructions and quickly exposed to high performance
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chemiluminescence film (Hyperfilm ECL) to detect the light emission. Bands were
quantified by laser scanning densitometry and analysed with suitable software
(UN-SCAN-IT, Silkscience, US).
3.8.2 PKB blots
Western blotting technique was carried out as stated (Ch 2.8.1) with minor
adjustments for specificity. Fractions (20J..lgprotein) were separated on a 12%
SDS-polyacrylamide gel. Membranes were incubated with the phospho-Akt
(Ser473) primary antibody (Cell Signaling Technology™) for 5 -16 hours at 4°C.
3.8.3 GLUT4 blots
Western blotting technique was carried out as stated (Ch 2.8.1) with minor
adjustments for specificity. Fractions (50J..lgprotein) were separated on a 10%
SDS-polyacrylamide gel, using the standard Bio-Rad Mini-PROTEAN III system
(Biorad, Life Science group, US).
Membranes were incubated with the GLUT4 (H-61): sc-7938 primary antibody
(Santa Cruz Biotechnology, Inc) (1:1000 dilution in TBS 0.02% Tween) for 5 - 16
hours at 4°C.
From this point onwards the membranes were washed with TBS 0.02%Tween
instead ofTBS 0.1%Tween.
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3.8.4 AMPK blots
Fractions (30Jlgprotein) were separated on a 10% SDS-polyacrylamide gel, using
the standard Bio-RadMini-PROTEAN III system (Biorad, Life Science group, US).
Membranes were incubated with the phospho-AMPK (Thr172) primary antibody
(1:1000 dilution in TBS 0.1% Tween, 5% BSA and 5% blocking agent) for 5 - 16
hours at 4°C. 5% blocking agent was also added to the secondary, horse-radish
peroxidase conjugated antibody.
3.9 Sarcolemmal Membrane and GLUT41soiation
GLUT4 translocates from an intracellular membrane compartment to the plasma
membrane. In order to determine if translocation occurred, these two cell
compartments needed to be carefully separated and the GLUT4 content per
milligram membrane protein determined.
The fractionation protocol had to render a sarcolemmal membrane component,
high in Na"K'ATPase activity and a cytosolic compartment containing no
Na+~ATPase activity, indicating an absence of contamination of the latter with
sarcolemmal membrane fractions. Furthermore a clear movement of GLUT4 from
the cytosolic to the membrane compartment should be detectable on Western
blotting of membraneswith GLUT4 after stimulation of hearts with insulin.
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A number of protocols (Ch 3.9.1-3.9.3) were tested for the fractionation of
membranes into sarcolemmal and cytosolic compartments before a final one (Ch
3.9.3) was selected as giving optimal pure fractions. Activity of the sarcolemmal
Na'K'Af'Pase enzyme (Bers, 1979) was used as a marker for this membrane
compartment, this enzyme only being present in the cell membrane. To validate
the protocol, fractionation was done on samples from control and insulin-
stimulated hearts. GLUT 4 content of these membranes was then tracked via
Western blotting.
When an optimal protocol was decided upon, cytosolic and membrane fractions
were isolated and GLUT 4 was visualised using the Western Blotting technique
and the specific antibody [GLUT 4 (H-61): sc-7938 primary antibody as described
above (Ch 3.8.3)
3.9.1 Protocol by Weber et al, 1988
Weber et al (1988) published a protocol for fractionation of rat adipocyte
membranes to track GLUT 4 trafficking.
For membrane fractionation, approximately 20mg of tissue, previously frozen in
liquid nitrogen, was homogenised on ice by polytron (2 x 5sec at setting 5) in
Buffer A (see addendum). These homogenates were centrifuged for 15minutes at
17000 x g (SorvalI RC-5B; rotor: SS34 with adapters for 12ml tubes; 12000rpm @
4°C). The supernatant (S1) of this centrifugation was kept while the pellet of this
centrifugation (P1) was washed once with Buffer A (SS34, 17000xg, 20min),
before it was resuspended in 1.5ml Buffer A, layered on a sucrose cushion and
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ultracentrifuged for 65 minutes at 65000 x g (Beckmann, 5W 65, 25000rpm). The
white interface was taken off, diluted with approximately 8ml Buffer A and the
membranes pelleted at 48000 x g (Beckman Ti50) for 30 minutes. The pellet was
then washed with 1ml Buffer A and the membrane fraction pelleted again, in an
Eppendorf tube in special adapters, at 48000 x g (TiSO) for 30 minutes. This
fraction was used as the membrane fraction.
To obtain a fraction containing the cytosolic glucose transporter pool, the
supernatant of the first centrifugation (51) was centrifuged for 30minutes at 48000
x g (Beckman Ti50). This resulted in the separation of a high-density microsome
fraction (which appears in the pellet of this centrifugation and is contaminated with
plasma membranes) and a low-density membrane fraction in the supernatant.
This supernatant was therefore ultracentrifuged (rotor: Ti60, 50000 rpm) for
65minutes at 250000 x g while the pellet was discarded.
3.9.2 Protocol modified from technique by Philipson et al, 1980
Philipson et al developed a membrane fractionation protocol in 1980 to prepare
purified sarcolemmal membranes from cardiac tissue.
Half a heart was homogenised in 5 ml of Buffer B (see addendum) by polytron on
setting 4 for 2 X 5 seconds. The homogenate was filtered through one layer of
nylon gauze (200 f.!M). 4 ml of Na-PPi-KCI solution (see addendum) was added to
every 36 ml of homogenate. This was then poured into rotor tubes and spun down
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for 60minutes in a Beckman Ultracentrifuge in the Ti50 rotor at 45 000 x g. The
resultant supernatant was taken as the cytosolic fraction.
The pellet was re-homogenised in Buffer C (see addendum). This was then
ultracentrifuged at 40 000 x g for 1 hour at 4°C (Beckman, rotor: Ti50), and the
supernatant was used as the membrane fraction.
3.9.3. Protocol by Takeuchi et al. 1998
Myocardial content of GLUT4 glucose transporters was visualised by Takeuchi et
al in 1998 by the following protocol.
Hearts perfused under control conditions and perfused with insulin and previously
stored in liquid nitrogen were homogenised on ice in TES buffer (see addendum).
The homogenate was centrifuged to remove particulate debris (1000 x g at 4°C
for 1Ominutes).
The supernatant (crude extract) was further fractionated by ultracentrifugation for
90minutes at 40 000 x g at 4°C (Beckman, Ti50). The supernatant was
considered to represent the cytosolic fraction, (no p-nitrophenylphosphatase
activity was detectable, indicating that this fraction was devoid of sarcolemmal
membrane elements). The pellet was suspended in the aforementioned buffer
minus sucrose and containing 1% (vol/vol) Triton X-100 and left on ice for
approximately half an hour.
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Afterwards the suspension was ultracentrifuged at 40 000 x g for 1 hour at 4°C
(Beckman, rotor:Ti50), and the supernatant used as the membrane fraction.
In each instance the cytosolic and membrane fraction protein concentration was
determined using the Bradford method. The samples were diluted in 3X Laemmli
sample buffer, boiled for 5 minutes and stored at -20°C. GLUT4 content and
distribution were determined by Western Blotting.
3.10 Measurement of sarcolemmal ouabain-sensitive paranitrophenyl
phosphataseactivity
Sarcolemmal membranes and cytoplasmic compartments were isolated as
described above. K+-dependent p-nitrophenylphosphatase (K+-pNPPase) was
used as a marker enzyme for the sarcolemmal membrane.
The hydrolysis of p-nitrophenylphosphate (pNPP) by the Na+K+ATPase enzyme
(K+-stimulated-p-nitrophenyl phosphatase) i.e. Na+K+ATPase activity was
measured in the appropriate reaction medium (see addendum). A duplicate assay
was also run with 10mM ouabain present so that the K+-stimulated and ouabain-
inhibited portion of the phosphatase activity could be measured.
The tubes with 0.1ml of homogenate or membrane fraction were pre-incubated in
a shaking waterbath at 25°C for 5 minutes before reaction medium (0.8ml) was
added with 15 second intervals followed by 0.1ml p-NPP to start the reaction. All
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enzyme incubations were carried out at 25°C. The reaction was quenched after
15 minutes by the addition of 1.5 ml 12%TCA.
The vials were then centrifuged at 12000 rpm at 4°C for 10 minutes. To the
supernatant, an equal volume of 0.5N NaOH was added, and the p-NP (p-
nitrophenol) produced was measured spectrophotometrically at-4-10nm-against a
0.5N NaOH blank.
Optical densities (ODs) obtained in the presence of ouabain were subtracted from
values obtained in its absence. A standard of p-nitrophenol was used to calculate
the activity of the enzyme which is expressed as nmol nitrophenol formed per
minute per mg protein (Bers, O.M. 1979)
3.10.1 Choice of an optimal membrane isolation method
3.10.1.1 Protocol by Weber et al, 1988
Weber et al (1988) published a protocol for fractionation of rat adipocyte
membranes to track GLUT4 trafficking.
In the resulting membrane pellet no ouabain sensitive p-nitrophenylphosphatase
activity was detectable, indicating that this fraction was void of plasma membrane.
Therefore this method was found to not be optimal for the isolation of a pure
sarcolemmal membrane compartment.
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3.10.1.2 Protocol modified from technique by Philipson et al. 1980
Philipson et al developed a membrane fractionation protocol in 1980 to prepare
purified sarcolemmal membranes from cardiac tissue.
In the resulting membrane pellet no ouabain sensitive p-nitrophenylphosphatase
activity was detectable, indicating that this fraction was void of plasma membrane.
Therefore this method was found to not be optimal for the isolation of a pure
sarcolemmal membrane compartment.
3.10.1.3. Protocol by Takeuchi et al. 1998
Myocardial content of GLUT4 glucose transporters was visualised by Takeuchi et
al in 1998 by the protocol described in Chapter 3.9.3.
The resulting membrane pellet was enriched with the plasma membrane marker
enzyme ouabain-sensitive p-nitrophenylphosphatase (see Chapter 3.10). Western
blot analysis for GLUT4 was done on basal and insulin-stimulated membrane
compartments. GLUT 4 could be seen in the membrane fraction, as well as its
increased translocation in the insulin-stimulated fraction compared to basal (See
Figure 3.4). Therefore this method was found to be the optimal method for
myocardial sarcolemmal membrane GLUT 4 analysis.
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Cytosolic GLUT4 Membrane GLUT4
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.'
48kDa~
Insulin (100nM) + +
Figure 3.4 Western blot showing membrane compartment GLUT4,
comparison between A) Protocol by Philipson et aI, 1980 and B) Protocol by
Takeuchi et al, 1998.
65
Stellenbosch University http://scholar.sun.ac.za
3.11 Bradford Protein Determination
The method of Bradford (Bradford, 1976) was used to determine the protein
content of fractions known to have low concentration of protein.
For reagents see addendum.
Standard Curve
Protein standards (bovine serum albumin, BSA in dH20) containing 1 to 20 Ilg
protein in a volume up to 0.1 ml was pipetted into 12 x 100 mm test tubes. The
volume in the test tube was adjusted to 0.1 ml with Millipore H20. 0.9 millilitres of
Bradford reagent (see addendum) was added to the test tube and the contents
mixed either by inversion or by vortexing. The absorbance at 595 nm was
measured after 15 minutes and before 30 minutes in 1ml cuvettes against a blank
prepared from 0.1ml of Millipore H20 and 0.9 ml of Bradford reagent. The
standard curve obtained in this manner was used to determine the protein content
of the unknown samples.
Protein assay
The membrane preparation was diluted 1 to 10 with dH20 in order to dilute all
detergents present (e.g. Triton-X) that may interfere with the assay. A suitable
aliquot of this dilution (e.g. 5 Ill) was adjusted to 0.1ml with dH20 before the
addition of 0.9ml Bradford reagent. The absorbance was measured in duplicate at
595 nM not less than 15 minutes but not more than 30 minutes after the addition
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of the Bradford reagent. The amount of the protein was determined using the
standard curve as described above.
The standard curve generatedwith Bradford reagent saturates at 20 ~g of protein!
sample. Samples were therefore always diluted to fall on the linear portion of the
curve.
3.12 Lowry Protein Determination
For reagents, see addendum.
1ml of 10% TCA was added to 100 ,.d of homogenate in a glass tube and left on
ice for at least 30 minutes to precipitate all protein. The sample was then
centrifuged at 2000 rpm for 10 minutes at 4°C and the supernatant carefully
decanted and discarded. The sides of the tubes were carefully blotted dry. The
precipitate was then dissolved in 1N NaOH in a water bath at 70°C. The solution
was diluted 1:1with dH20, rendering a O.SNNaOH solution.
The assay was done in triplicate on 50 ,.d of sample or standard (3 different BSA
solutions of known concentration dissolved in O.SNNaOH) or O.SNNaOH (blank),
in Luchamtubes.
1 ml of Work solution 2 was added to the 50 ,..d of sample or standard or blank,
mixed well and allowed to stand for 10 minutes at room temperature. 0.1 ml of
work solution 1 was added and very rapidly vortexed. After at least 30 minutes,
the colour development was read in a spectrophotometer at 750 nm against the
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blank. The unknown protein concentrations were plotted from the standard curve
(Lowry et al, 1951).
3.13 STATISTICAL ANALYSES
In all instances, significance of observed effects was determined using Microsoft
GraphPad Prism. The one way analysis of variance (ANOVA) with Bonferroni
corrections for multiple comparisons or the paired Students t-test were used for
comparisons between 2 groups. All values are expressed as mean ± standard
error of the mean (SEM). A p-value smaller than 0.05 was considered significant.
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ADDENDUM CHAPTER 3
Isolation of Cardiomyocytes:
Medium A: 6mM KCI,
1mM Na2HP04,
O.2mM NaH2P04,
1.4mM MgS04,
128mM NaCl,
10mM NaHEPES,
5.5mM O-glucose,
2mM pyruvate.
medium A containing 0.7% fatty acid-free BSA,
1.1mg collagenase per ml
and 15mM BOM.
medium A containing 400~M CaCh,
1%BSA,
and 1% fatty acid-free BSA.
medium A containing 1.25mM CaCh
and 2% albumin, fatty acid-free, but no BOM.
medium A without glucose, pyruvate or BOM
but with 2% albumin, fatty acid-free and 1.25 mM CaCh
Medium B:
Medium C:
Medium 0:
Medium E:
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Cell Viability
Hypotonic Medium D: medium D diluted 1:1 with deionised water, containing 5mM
KCN.
Counting Medium: hypotonic medium D,
5mM KCN,
0.5% glutaraldehyde
and 1% trypan blue.
Detection of Glucose Uptake
Assay medium E: 6mM KCL,
1mM Na2HP04,
1.4mM MgS04,
128mM NaCI,
10mM HEPES,
1mM CaCh,
2% BSA, fatty acid free.
PKB/Akt Lysis Buffer
20mM Tris-HCL (pH7.4),
1mM EGTA,
25mM NaCI,
1mM Na3V02,
70
Stellenbosch University http://scholar.sun.ac.za
10mM NaF,
1% (vol/vol) Triton X-100,
leupeptin (1Oug/ml),
aprotonin (10ug/ml),
1mM benzamidine
1mM phenylmethyl-sulphonyl fluoride (PMSF). (added immediately before use).
GLUT4 Lysis Buffers
Protocol by Weber et al (1988):
Buffer A: 20mM Tris,
1mM EDTA,
250mM sucrose; pH 7.4
Sucrose Cushion buffer: 38% (wtlvol) sucrose,
20mM Tris,
1mM EDTA; pH 7.4
Protocol by Phillipson et al (1980):
Buffer B: 20mM Tris,
1mM EDTA,
250mM sucrose; pH 7.4
Na-PPi-KCI solution: 0.25M sodium pyrophosphate (NaPPi)
3MKCI
Buffer C: Buffer B minus sucrose and
containing 1% (vol/vol) Triton X-100
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Protocol by Takeuchi et al (1998):
TES buffer: Tris-HCI 20mM (pH 7.S),
sucrose 330mM,
EOTA2mM,
EGTAO.SmM,
PMSF 1mM and
2SJ.lg/ml leupeptin.
Laemmli Sample Buffer
3 x stock: O.SMTris (3.03g/S0ml)
0.4% SOS (2ml of 10% ISOmi)
pH 6.6 with HCI
take 33.3ml of this + 8.8g SOS
+20g glycerol
+ 0.01g bromo phenol blue
Make to 7Sml with ddH20
8S0J.l1of the above + 1S0J.l1mercaptoethanol = sample buffer
Oilute sample 1 in 3 with sample buffer, boil for 5 minutes before freezing.
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Perfusion Buffer
Krebs-Henseleit bicarbonate buffer: 119mM NaCl,
25mM NaHC03,
4.75mM KCI,
1.185mM KH2P04,
0.6mM MgS04
0.6mM NaS04
1.25mM CaC12.2H20
5mM glucose
Perfusion buffer gassed with 95% 02 I 5% C02
SOS-polyacrylamide gel
4% Stacking Gel:
12% Separating Gel:
3.05ml Millipore H20;
1.25ml 0.5M Tris-HCI pH 6.8;
50JlI 10% SOS;
500JlI Acrylamide;
50JlI APS (0.1 gImi);
10JlI TEMEO.
3.35ml Millipore H20;
2.5ml 1.5M Tris-HCI, pH 8.8;
100JlI 10% SOS,
3ml Acrylamide;
50JlI APS (0.1 g/ml) and
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10% Separating Gel:
20111TEMEO.
4.9ml Millipore H20;
2.5ml 1.5M Tris-HCI, pH 8.8;
10011110% SOS,
2.5ml Acrylamide;
50111APS (0.1g/ml) and
20111TEMEO.
Ouabain-sensitive pNPPase activity assay
Reaction medium, ouabain free: 50mM imidasole (pH 7.5, HCI),
5mM MgCI2,
5mM EGTA,
10mM KCI
Reaction medium, containing ouabain: 50mM imidasole (pH 7.5, HCI),
5mM MgCb,
5mM EGTA,
10mM KCI
1mM ouabain
Nitrophenol Standard: 50 ~M
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Bradford Reagents
Coomassie Brilliant Blue G-250 (100mg) was dissolved in 50ml 95% ethanol. To
this solution 100ml 85% (w/v) phosphoric acid was added. The resulting solution
was diluted to a final volume of 1 litre. Final concentrations in the reagent were
0.01% (w/v) Coomassie Brilliant Blue G-250, 4.7% (w/v) ethanol, and 8.5% (w/v)
phosphoric acid.
Lowry Reagents
Stock Solutions:
Reagent A: 10% cold TCA
Reagent B: 2% Na-K-Tartrate in dH20.
Reagent C: 1% CuS04.5H20 in dH20
Reagent D: 2% Na2C03 in dH20
Reagent E: Folin-Ciocalteu's phenol reagent
Albumin stock standard
500mg albumin 110ml H20, dissolve; dilute 50J.l1with 5ml H20
read at 280nm against H20 to determine concentration
Molar extinction coefficient: 1.51
Work Solutions
Work solution 1: Mix 0.5ml Reagent Band 0.5ml Reagent C with 49ml
Reagent D.
Work solution 2. Dilute Folin 1 in 3.
Standard: dilute albumin stock standard 1 in 200 with 0.5N NaOH.
75
Stellenbosch University http://scholar.sun.ac.za
CHAPTER4
RESULTS
4.1 AMPK activation
To determine whether the 2 pharmacological substances, AICAR and ZMP, could
exert physiological effects via activation of AMPK, the ability of these compounds
to elicit phosphorylation of the kinase was determined. This was accomplished by
measuring AMPK activation in terms of its phosphorylation on Thr 172 via
Western Blotting and a specific antibody (Cell Signaling) as described in Materials
and Methods (Chapter 3). In cardiomyocytes treated with AICAR (1 mM for 30
minutes) and ZMP (1 mM for 30 minutes) it was found that both substances
resulted in phosphorylation of AMPK, increasing levels significantly above basal
(see Figure 4.1). A heart subjected to ischaemia was included as a positive
control.
4.2 AICAR concentration curve
To evaluate which concentration of AICAR was optimal, a concentration curve of
glucose uptake was established in cardiomyocytes using 50 JlM, 100 JlM, 500 JlM,
1 mM, 2 mM, 5 mM and 10 mM of AICAR. Glucose uptake was also measured as
2DG uptake in the presence of these AICAR concentrations and 100 nM Insulin.
AICAR attenuated glucose uptake at all concentrations. AICAR was also seen to
attenuate insulin stimulated glucose uptake in dose dependent manner. At 1 mM
AICAR a significant attenuation of both basal and insulin mediated glucose uptake
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was noticed. This, and the fact that this concentration was used in the other
literature (Russell et ai, 1999), led us to use 1 mM AlGAR in the following
experiments (see Fig 4.2).
4.3 AICAR and ZMP Time Curves
In order to select an optimal time for stimulation with the pharmaceutical agents in
these experiments, a time curve was done. Gardiomyocytes were stimulated with
AlGAR (1 mM as previously established) for 15 minutes, 30 minutes and 60
minutes (see figure 4.3) and with ZMP (1 mM) for 15 minutes, 30 minutes and 60
minutes (see Fig 4.4). Glucose uptake was then assessed by measurement of
2DG uptake. AlGAR and ZMP stimulation for 30 minutes gave reproducible and
reliable results while stimulation for the longer time periods nearly abolished all
glucose uptake and therefore 30 minutes was chosen as the time of stimulation
for following experiments.
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4.4 GLUCOSE UPTAKE
4.4.1 AICAR effect on glucose uptake
The mean response of cardiomyocytes to 1 mM AICAR over a 30 minute period
with regards to glucose uptake was determined. This was done in the presence or
absence of insulin (100 nM, 15 minutes). While stimulation with insulin (100 nM)
increased glucose uptake significantly in isolated cardiomyocytes from basal (1
standardised unit ± 0) to 4.5 ±D.6 fold (p<0.05), AICAR (1 mM) was seen to elicit a
glucose uptake of 0.7 ±D.1 which was significantly lower (p<0.05) than basal
levels of glucose uptake. In the presence of AICAR, insulin-stimulated glucose
uptake was significantly attenuated (2.6±0.48 vs 4.5±0.6 fold p<0.05)) (see Fig
4.5).
4.4.2 ZMP effect on glucose uptake
Javaux et al (1995) reported that rabbit cardiomyocytes were unable to
phosphorylate AICAR to ZMP. Because of the observed inability of AICAR to elicit
glucose uptake in rat cardiomyocytes we tested the ability of ZMP to affect
glucose uptake. This was again done in the presence or absence of insulin (100
nM, 15 minutes). As above, insulin was seen to significantly stimulate glucose
uptake from basal levels (1 ±D to 7.3 ±D.8 fold, p<0.05). ZMP significantly lowered
basal glucose uptake levels to 0.8 ±D.2 and was able to significantly attenuate
insulin stimulated glucose uptake to 4.1 ±D.7(p<0.05)when the ZMP (1 mM) was
administered 15 minutes before the insulin (see Fig 4.6).
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However, this attenuation of insulin stimulated glucose uptake was abolished
when the insulin was administered only 5 minutes before the ZMP instead of 15
minutes after ZMP (see Figure 4.7). Insulin was then present throughout the
experiment.
4.5 PKB/Akt PHOSPHORYLATION
Ponceau-S reversible staining was routinely used to determine equal protein
loading and transfer during Western blotting. Figure 4.8 is an example of such a
stain.
4.5.1 AICAR effect on PKB/Akt phosphorylation
Since there was a noticeable attenuation in insulin stimulated glucose uptake by
AlGAR, and since basal glucose uptake was suppressed by the drug, PKB/Akt
phosphorylation patterns were measured by Western blotting to determine
whether this pathway of glucose uptake was affected or not. Gardiomyocytes were
again incubated with AlGAR (1 mM, 30 minutes) in the presence or absence of
insulin (100 nM, 15 minutes). The cells were then lysed, total protein isolated and
subjected to Western blotting to determine phosphorylation on the Ser473 by use
of a specific antibody (Geil Signaling) as described in Materials and Methods
(Chapter 3).
Both 100 nM insulin alone (4.2 ± 0.5 arbitrary densitometry units) and 100 nM
insulin plus 1 mM AlGAR (4.0 ± 0.5 arbitrary densitometry units) stimulated
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PKB/Akt phosphorylation to a similar extent above basal levels (1 ± 0.0
standardised arbitrary densitometry unit; p<0.01; n=12 ). The presence of AICAR
therefore did not attenuate insulin stimulated PKB phosphorylation. AICAR 1 mM
(0.8 ± 0.2) however, was unable to affect PKB/Akt phosphorylation beyond basal
levels (See Fig 4.9 & 4.10).
4.5.2 ZMP effect on PKB/Akt phosphorylation
Cardiomyocytes were again incubated with ZMP (1 mM, 30 minutes) in the
presence or absence of insulin (100 nM, 15 minutes). The cells were then lysed
and subjected to Western blotting done to determine phosphorylation on the
Ser473 by use of a specific antibody (Cell Signaling) as described in Materials
and Methods (Chapter 3).
Insulin 100 nM significantly increased PKB/Akt phosphorylation (3.3 ± 0.4 arbitrary
densitometry units, p<0.05) above basal levels. ZMP (1 mM) was not seen to
have an effect on PKB/Akt phosphorylation. Similar to AICAR, ZMP (1 mM) did
not attenuate the level of PKB/Akt phosphorylation elicited by 100 nM insulin. The
combination of ZMP and insulin showed a tendency towards an accumulative
effect. However this was not statistically significant (4.9 ± 1.3 arbitrary
densitometry units). The attenuation of the effect of insulin by ZMP seen in the
glucose uptake, was therefore not evident in the PKB/Akt phosphorylation pattern
(see figure 4.11) observed under identical conditions.
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4.6 Effect of Wortmannin on Glucose Uptake
It is known that inhibition of PI3-K with wortmannin inhibits insulin-stimulated
glucose uptake by cardiomyocytes (Lefebvre et aI, 1996). It is also stated that
wortmannin does not inhibit AMPK mediated glucose uptake (Hayashi et aI,
1998). We assessed in our cardiomyocyte system, the effects of wortmannin on
insulin, AICAR and ZMP mediated effects. Cells were incubated with AICAR (1
mM, 30 minutes), insulin (100 nM, 15 minutes) and wortmannin (100 nM, 15
minutes before addition of either insulin, AICAR or ZMP) in the combinations set
out in Chapter 3.
100 nM wortmannin abolished glucose uptake stimulated by insulin (Figure 4.13
and 4.14) having no effect on the response of AICAR and ZMP. In the presence of
AICAR, wortmannin abolished insulin mediated glucose uptake while in the
presence of ZMP, it was observed that glucose uptake was not completely
suppressed.
4.7 Effect of Wortmannin on PKB/Akt phosphorylation
In view of the known link between activation of PKB/Akt by insulin and insulin-
stimulated glucose uptake, we determined the effect of wortmannin on PKB/Akt
phosphorylation after stimulation with insulin in the presence or absence of AICAR
and ZMP.
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4.7.1 Wortmannin and AICAR effect on PKB/Akt phosphorylation
The effect of wortmannin and AICAR on the phosphorylation of PKB/Akt was
determined using Western blotting techniques and a specific Ser473 antibody
(Cell Signaling Technology) as described in Chapter 3. Cells were incubated with
AICAR (1 mM, 30 minutes), insulin (100 nM, 15 minutes) and wortmannin (100
nM, 15 minutes before addition of either insulin, AICAR or ZMP) in the
combinations set out in Chapter 3.
As was expected, wortmannin inhibited insulin stimulated PKB/Akt
phosphorylation from 4.2 ±O.5arbitrary densitometry units to 1.3±O.1(p<0.05) as
well as PKB/Akt phosphorylation seen with insulin in combination with AICAR
(4.0±0.5 arbitrary densitometry units to 1.9±O.3,p<0.05). It had no effect on either
basal (1.0±O to 1.0±O) or AICAR stimulated PKB/Akt phosphorylation (0.8±O.2
arbitrary densitometry units to 1.0±0.2) (See Fig 4.15 and Fig 4.16).
3.7.2 Wortmannin and ZMP effect on PKB/Akt phosphorylation
The effect of wortmannin and ZMP on the phosphorylation of PKB/Akt was
determined using Western Blotting techniques and a specific Ser473 antibody
(Cell Signaling Technology) as described in Chapter 3. Cells were incubated with
ZMP (1 mM, 30 minutes), insulin (100 nM, 15 minutes) and wortmannin (100 nM,
15 minutes before the addition of either insulin, AICAR or ZMP) in the
combinations set out in Chapter 3.
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As was expected, wortmannin inhibited insulin stimulated PKB/Akt
phosphorylation from 3.3 ±O.4arbitrary densitometry units to 0.72 ± 0.02 arbitrary
densitometry units (p<0.05), while having no effect on basal phosphorylation of
PKB/Akt (1.0±0.01 to 0.9±O.06). The PKB/Akt phosphorylation elicited by the
combination of insulin and ZMP (4.9±1.3 arbitrary densitometry units) was
decreased by the addition of wortmannin (2.7±O.8 arbitrary densitometry
units)(p<0.05). However the addition of wortmannin to ZMP significantly increased
phosphorylation levels of PKB/Akt from that of ZMP alone (1.1 ± 0.05 to 1.9±O.3,
p<005) (See Fig 4.17 and Fig 4.18).
4.8 Effect of 8ePT on AMPK phosphorylation
ZMP is the phosphorylated form of AICAR. According to current knowledge such
a phosphorylated molecule should not be able to enter the cell. It was speculated
that perhaps ZMP, because of its AMP analogue nature, was exerting its
intracellular effects like phosphorylation of AMPK, by binding to the adenosine
receptors (purinergic receptors). Similarly AICAR could bind to the receptors to
elicit effects. To investigate this possibility, a blocker of these receptors, 8CPT,
was used in conjunction with AICAR and ZMP. Cells were incubated with the
blocker 15 minutes before stimulation with either AICAR (1 mM, 30 minutes) or
ZMP (1 mM, 30 minutes). Western blot analysis was then carried out using
phosphorylated AMPK Thr 172 specific antibodies (Cell Signaling Technology).
ZMP and AICAR both resulted in phosphorylation of AMPK above basal levels
(ZMP: 1.5 ±0.1, AICAR: 1.8 ±0.2, p<0.05). 8CPT had no significant effect on ZMP
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or AICAR induced phosphorylation of AMPK (See Fig 4.19 & Fig 4.20) confirming
that both substances did not act through activation of the purinergic receptors to
affect AMPK phosphorylation.
4.9 GLUT4 Translocation in cardiomyocytes
GLUT 4 is the glucose transporter that is recruited to the cell membrane of insulin
and stress stimulated cells (see Chapter 2). It translocates from the cytosol to the
membrane, and is responsible for glucose uptake. Because of the observed
inhibitory effects of AICAR and ZMP on insulin-stimulated glucose uptake but not
on PKB/Akt phosphorylation, as well as results showing activation of AMPK by
these substances but not glucose uptake, we assessed GLUT 4 translocation
under these conditions. GLUT4 translocation was assessed by treating the cells
with various sequences of AICAR (1 mM, 30 minutes), ZMP (1 mM, 30 minutes),
and insulin (100 nM, 15 minutes), fractionating the cells into cytosolic and
membrane compartments, and then doing Western Blots with specific GLUT 4
antibody on these two compartments (See Figs 4.21 - 4.25).
4.9.1 GLUT4 Content in the cytosolic compartment
No significant difference in cytosolic GLUT 4 content could be seen between basal
(1.0 ± 0.02 arbitrary densitometry units) and insulin stimulated cells (0.9 ± 0.1
arbitrary densitometry units), but the standard error in this group was quite large.
There was however a significant decrease in the cytosolic GLUT4 content of
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AICAR (0.9 ± 0.04) and ZMP (0.9±O.05) (p<0.05) stimulated cells, showing a
translocation away from the cytosol (See Fig 4.21 & 4.22).
4.9.2 GLUT4 Content in the membrane compartment
A significant increase in GLUT 4 translocation could be seen between basal
(1.1±O.01arbitrary densitometry units) and insulin stimulated cells (1.5±O.2), as
well as between basal and AICAR (1.3±O.10) and basal and ZMP treated cells
(1.6±O.1). This shows that the GLUT4 translocated away from the cytosol and
into the membrane in insulin, AICAR and ZMP stimulated cells (See Fig 4.23 &
4.24). However, when insulin was added in combination with either AICAR or
ZMP, only the AICAR + insulin combination gave a significantly higher than basal
GLUT4 translocation (1.2±O.2, p<0.05), whilst ZMP + insulin (1.2±O.3) was not
significantly increased (see Fig 4.25).
4.10 GLUT4 translocation in whole hearts
Since a very small amount of protein is obtained from cardiomyocyte preparations,
the whole heart was used to see whether similar results could be obtained. Whole
hearts were perfused with either AICAR (1 mM) for 30 minutes, ZMP (1 mM) for
30 minutes, or insulin (100 nM) for 15 minutes, in both 5 mM glucose medium and
in glucose free medium. The latter was included because myocytes were treated
in a glucose-free medium. Lysates were then made and Western blots done on
the protein for GLUT4 (See Figs 4.26 - 4.30).
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4.10.1 GLUT 4 content in cytosolic compartment
In the whole heart no significant GLUT 4 translocation could be detected from the
cytosolic fraction in either the glucose free or the 5 mM glucose perfused hearts.
Basal (1±O arbitrary densitometry units), insulin (1.1±O.1), AICAR (0.9±O.1) and
AICAR + insulin (1.3±O.3) GLUT4s showed no significant differences (See Fig
4.26) when perfused with 5 mM glucose medium. Basal (1±O arbitrary
densitometry units), insulin (1.0±O.1), AICAR (1.0±O.04) and AICAR + insulin
(1.0±O.06) GLUT4s showed no significant differences (See Fig 4.29) in the
cytosolic fraction of hearts perfused with a glucose free medium.
4.10.2 GLUT 4 content in membrane compartment
In the whole heart although a pattern can be seen in increasing GLUT4
translocation to the membrane with insulin, AICAR and ZMP, these differences
were not significant due to large standard errors (See Fig 4.27, 4.28 and 4.30).
Basal (1±O arbitrary densitometry units), Insulin (1.4±O.2), AICAR (1.6±O.5) and
the AICAR, insulin combination (2.0±O.8) GLUT4s showed no significant
differences in 5 mM perfused hearts (see Fig 4.27). Basal (1±O arbitrary
densitometry units), insulin (1.1±O.2), AICAR (1.2±O.3) and AICAR plus insulin
(1.6±O.42) GLUT4s showed no significant difference in whole hearts perfused with
glucose free medium (see Fig 4.29).
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4.11 p38 MAPKinase
lt has been put forward (Xi et al, 2001) that MAPKinases, especially p38 MAPK,
play a role in glucose uptake. Therefore glucose uptake was measured in the
presence and absence of S8203580 (Calbiochem), a specific blocker of p38.
Cells were stimulated with ZMP, insulin, and a combination of the two, in the
presence or absence of 1 j.JMS8203580, and the glucose uptake measured.
1 j.JMS8203580, added 5 minutes before ZMP, had no effect on glucose uptake
in the basal (1±O standardised unit and 0.6±O.5), insulin (8.3±2.4 and 7.7±2.4),
ZMP (1.4±O.4 and 0.6±O.4) or combination ZMP and insulin stimulated cells
(3.3±1.1 and 4.7±1.8) (See Fig 4.31).
Due to time constraints only one Western blot was done on the p38 MAPK
phosphorylation pattern (See Fig 4.32). When the p38 MAPK phosphorylation
pattern was analysed, it was seen that the phosphorylation of p38 MAPK
increased from basal (1 arbitrary densitometry unit) with insulin stimulation (1.705
arbitrary densitometry units) and further increased with ZMP activation (2.3
arbitrary densitometry units). The insulin and ZMP combination was 1.8 arbitrary
densitometry units, similar to insulin-stimulated levels (see Fig 4.32).
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ADDENDUM CHAPTER 4
*
4.0
3.5
•~
C 3.0:s
e
15 2.5
E
0-ii 2.0
C
CD
"C
e 1.5
f-:e 1.0
c(
0.5
0.0
Basal ZMP AICAR Ischaemia
Figure 4.1: Phosphorylation of AMPK on Thr 172 in cardiomyocytes in control
conditions, when activated by 30 minutes stimulation with ZMP (1mM) or
AICAR (1mM) and when under stress i.e. ischaemia (positive control).
All values are expressed as mean ± SEM (n = 4),
* p<0.05 vs basal
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Figure 4.2 Concentration curve of the effect of AICAR (30 min stimulation) on
cardiomyocyte glucose uptake with and without insulin. Insulin (100 nM) was
added to cells 15 min after the addition of ZMP, total incubation time 30 min,
before the addition of 2DG for a further 30 min incubation.
All values expressed as mean ± SEM (n=2-4)
* p < 0.05 - vs + insulin
**p<0.05 AICAR vs basal
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Figure 4.2 Concenb'ation curve of the effect of AICAR (30 min stimulation) on
cardiomyocyte glucose uptake with and without insulin. Insulin (100 nM) was
added to cells 15 min after the addition of ZMP, total incubation time 30 min,
before the addition of 2DG for a further 30 min incubation.
All values expressed as mean ± SEM (n=2-4)
* p < 0.05 - vs + insulin
**p<0.05 AICAR vs basal
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Figure 4.4: The effect of ZMP (1 mM), given for varying time periods, on
cardiomyocyte glucose uptake. Insulin was given for 15 min and used as a
positive control.
All values expressed as mean ± SEM (n = 1-6, assayed in duplicate)
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Figure 4.5: Effect of AICAR (1 mM) and insulin (100 nM) on cardiomyocyte
glucose uptake when insulin was administered 15min after the addition of
AICAR - total stimulation time 30 min before the addition of 2DG.
All values expressed as mean ± SEM (n=11, assayed in duplicate)
* p<0.05, vs basal,
** p < 0.05, vs insulin
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Figure 4.6: Effect of ZMP (1 mM) and insulin (100 nM) on cardiomyocyte
glucose uptake, when insulin was administered 15 min after ZMP
administration. Total incubation time 30 min before addition of 20G.
All values expressed as mean ± SEM (n=8, assayed in duplicate)
* p<O.05 vs basal,
** p<O.05 vs insulin
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Figure 4.7: Effect of ZMP (1 mM) and insulin (100 nM) on cardiomyocyte
glucose uptake when insulin was administered 5 min before ZMP
administration. Total incubation time 35 min before the addition of 2DG.
All values expressed as mean ± SEM (n=7, assayed in duplicate)
* p<O.05 vs basal,
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Figure 4.8: Ponceau S scan of a Western Blot to show equal concentration of
bands and adequate transfer of proteins to the membrane.
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Figure 4.9: Effect of AICAR (1 mM) and insulin (100 nM) on PKB/Akt
phosphorylation. Cells were stimulated with AICAR for 30 min and with insulin
for 15 min.
All values expressed as mean ± SEM (n=12).
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Figure 4.10: Western blot showing phosphorylation pattern of PKB/Akt on
Ser473 phosphorylation by 1mM AICAR (30min) and 100nM insulin (15min).
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Figure 4.11: Effect of ZMP (1 mM) and insulin (100 nM) on PKB/Akt
phosphorylation. Cells were stimulated with ZMP for 30 min and with insulin for
15 min.
All values expressed as mean ± SEM (n=9)
p < 0.05 vs basal
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Figure 4.12: Western blot showing PKBlAkt phosphorylation pattern (Ser473)
by 1mM ZMP (30 min) and 100nM insulin (15 min).
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Figure 4.13: Effect of wortJnannin (100nM) on glucose uptake in insulin (100
nM) and AICAR (1 mM) stimulated cardiomyocytes. Wortmannin was
administered 15 min before the addition of either AlCAR or insulin, and
remained in the incubation medium for the duration of the experiment Cells
were stimulated with AlCAR for 30 min and with insulin for 15 min.
All values expressed as mean ± SEM (n= 3-12, assayed in duplicate)
* p < 0.05 -wortmannin vs + wortmannin
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Figure 4.14: Effect of wortmannin (100 nM) on glucose uptake In Insulin (100
nM) and ZMP (1 mM) stimulated cardiomyocytes. Wortmannin was
administered 15 min before the addition of either ZMP or Insulin, and remained
in the incubation medium for the duration of the experiment. Cells were
stimulated with ZMP for 30 min and with insulin for 15 min.
All values expressed as mean ± SEM (n= 3-12, assayed in duplicate)
* p < 0.05 -wortmannin vs +wortmannin
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Figure 4.15: Effect of wortmannin (100 nM) on PKB/Akt phosphorylation in
insulin (100 nm) and AICAR (1 mM) stimulated cardiomyocytes. Wortmannin
was added 15 min before the addition of either AlCAR or insulin, and remained
In the medium throughout the experiment. Cells were stimulated with AICAR
for 30 min and insulin for 15 min.
All values expressed as mean ± SEM (n=8-12)
* p<0.05 - wortmannin vs +wortmannin
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Figure 4.16: Western blot showing PKB/Akt phosphorylation pattern (Ser 473)
in cells stimulated with AlCAR (1 mM), insulin (100 nM) and wortmannin (100
nM) as indicated in Fig 4.15.
101
Stellenbosch University http://scholar.sun.ac.za
• 6-C
::::J 5e..
E 4o-ii
i 3
'tJ
e
f 2-:e
ct 1
0- wortmannin
7 0+ wortmannin
*
~.__
*
#
T
~
*T ~
- r---n I
Figure 4.17: Effect of wortmannin (100 nM) on PKBlAkt phosphorylation in
o
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insulin (100 nm) and ZMP (1 mM) stimulated cardiomyocytes. Worbnannin was
Insulin
added 15 min before administration of ZMP or insulin, and present throughout
the experiment. Cells were stimulated with ZMP for 30 min, and with insulin for
15 min.
All values expressed as mean ± SEM (n=5-10)
* p<0.05 -wortmann in vs + wortmannin
# p<0.05 vs insulin +wortmannin
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Figure 4.18: Western blot showing PKB/Akt phosphorylation pattern (Ser 473)
in cardiomyocytes stimulated with ZMP (1 mM), insulin (100 nM) and
wortmannin (100 nM) as indicated in Fig 4.17.
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Figure 4.19 The effect of the purinergic receptor blocker, 8CPT (10 JIM), on
AlCAR (1 mM) and ZMP (1 mM) phosphorylation of AMPK on Thr 172 in
cardiomyocytes. 8CPT was added to cells 15 min before the addition of
AlCAR (1 mM) or ZMP (1 mM). Cardiomyocytes were stimulated with AI CAR
or ZMP for 30 min.
All values are expressed as mean ± SEM (n = 4),
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Figure 4.20 Western blot to show AMPK phosphorylation on Thr 172 in
cells treated with AICAR (1 mM) or ZMP (1 mM) and blocked with SePT (10
11M).Hypoxic cells were used as a positive control.
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Figure 4.21 Cytosolic distribution of GLUT4 in basal, insulin (100 nM),
Basal AlCAR
AlCAR (1 mM) and ZMP (1 mM) treated cardiomyocytes. Cells were
Insulin ZMP
stimulated with AlCAR or ZMP for 30 min or with insulin for 15 min.
All values are expressed as mean ± SEM (n = 12),
* = p<O.05 vs basal
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Figure 4.22 Western blot to show content of GLUT4 in the cytosol of
cardlomyocytes treated with AICAR (1 mM), ZMP (1 mM) and Insulin (100
nM).
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Figure 4.23 Membrane comparbnent disbibution of GLUT4 in basal, insulin
(100 nM), AICAR (1 mM) and ZMP (1 mM) treated cardiomyocytes. Cells
were stimulated with AlCAR or ZMP for 30 min or with insulin for 15 min.
All values are expressed as mean 1: SEM (n = 12),
* = p<0.05 vs basal
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Figure 4.24 Western blot to show content of GLUT4 in the membrane of
cardiomyocytes treated with AlCAR (1 mM), ZMP (1 mM) and insulin (100
nM).
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Figure 4.25 Membrane comparbnent distribution of GLUT4 in basal, insulin
(100 nM), AICAR (1 mM), ZMP (1 mM) and a combination of AICAR and
insulin or ZMP and insulin treated cardiomyocytes. Stimulation with insulin
was for 15 min, and with AlCAR or ZMP for 30 min.
All values are expressed as mean ± SEM (n = 5-15),
* = p<0.05 vs basal
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Figure 4.26 GLUT4 content of the cytosolic fraction of whole hearts
perfused with 5 mM glucose under basal, insulin (100 nM), AICAR (1 mM)
and a combination of AICAR and insulin conditions. Cells were stimulated
with insulin for 15 min, and with AICAR for 30 min.
All values are expressed as mean ± SEM (n = 6)
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Figure 4.27 GLUT4 content of the membrane fraction of whole hearts
perfused with 5 mM glucose under basal, insulin (100 nM), AICAR (1 mM)
and a combination of AICAR and insulin conditions. Cells were stimulated
with insulin for 15 min, and with AICAR for 30 min.
All values are expressed as mean ± SEM (n = 6)
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Figure 4.28 Western blot to show membrane content of GLUT4 in whole
hearts perfused with 5 mM glucose under basal, insulin (100 nM), AICAR (1
mM) and a combination of AICAR and insulin conditions.
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Figure 4.29 GLUT4 content of the cytosolic fraction of whole hearts
perfused with glucose free medium under basal, insulin (100 nM), AlCAR (1
mM) and a combination of AlCAR and insulin conditions. Cells were
stimulated with insulin for 15 min, and with AICAR for 30 min.
All values are expressed as mean ± SEM (n = 7)
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Figure 4.30 GLUT4 content of the membrane fraction of whole hearts
perfused with glucose free medium under basal, insulin (100 nM), AICAR (1
mM) and a combination of AICAR and insulin conditions. Cells were
stimulated with insulin for 15 min, and with AICAR for 30 min.
All values are expressed as mean ± SEM (n = 7)
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Figure 4.31: Effect of 5B203580 (p38-MAPK inhibitor, 10 iJM) on glucose
uptake In insulin and ZMP (1 mM) treated cardiomyocytes. 5B203580 was
added 5 minutes before either insulin, ZMP or AICAR and left in the
medium for the duration of the experiment Cells were stimulated with ZMP
for 30 min, and with insulin for 15 min.
All values are expressed as mean ± SEM (n = 3)
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Figure 4.32: p38-MAPK phosphorylation in insulin (100 nM), ZMP (1 mM)
and ZMP and insulin stimulated cardiomyocytes. Cells were stimulated with
ZMP for 30 min, and with insulin for 15 min.
All values are expressed as mean ± SEM (n = 1)
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Chapter 5
DISCUSSION
Regular exercise enhances insulin sensitivity in insulin resistant humans and rodents
(Davis et aI, 1986; Braun et aI, 1995). This is manifested in increased insulin
stimulated glucose uptake (Braun et aI, 1995). Exercise leads to increased AMPK
activity (Musi et aI, 2003). It is therefore postulated that the AMPK biochemical
pathway will cross talk with the insulin biochemical pathway. AlGAR is said to
activate AMPK (Gorton et aI, 1995), therefore pharmacological manipulation with
AlGAR should affect an increased insulin stimulated glucose uptake or insulin
stimulated PKB/Akt phosphorylation as evidence of increased insulin signaling.
In view of the above we hypothesized that stimulation of the heart with AlGAR or
ZMP would lead to a sensitization of the heart muscle for insulin stimulation, and we
therefore aimed to determine:
i) Whether AlGAR can activate AMPK in heart muscle
ii) Whether this pharmacological activation will mimic some of the
physiological effects of exercise e.g. increased glucose uptake and GLUT4
translocation
iii) Whether AlGAR, in any way, affects the biochemical pathway activated by
insulin and leading to glucose uptake.
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5.1 AMPK phosphorylation
Adult ventricular myocytes were stimulated with AlGAR (1 mM) for 30 minutes. This
increased AMPK phosphorylation of Thr 172 significantly (see Fig 4.1). This result
corroborates findings in EDL skeletal muscle (Lemieux et ai, 2003) and hypothalamic
cells (Perrin et ai, 2004). However, Longnus et al (2003) were unable to elicit AMPK
activation with AlGAR in ventricular tissue. In view of the findings by Javaux et ai,
1995 that in cardiomyocytes, AlGAR is probably not phosphorylated to ZMP, we
similarly tested the effect of ZMP on AMPK phosphorylation (see Fig 4.1) and found
increased phosphorylation of Thr 172, indicating that ZMP indeed results in
phosphorylation of AMPK in isolated cardiomyocytes. However, neither the activity of
AMPK nor the activity of downstream targets of AMPK e.g. AGGj3 and glycogen
syntase were measured, suggesting a possibility that AMPK was phosphorylated but
not actually activated.
There has also been positive evidence for ZMP activation of AMPK in hepatocytes
(Gorton et ai, 1995). It was postulated that ZMP, due to its AMP analogue nature,
acted via the purinergic receptors and thus bringing about its intracellular effect
(Fischer et ai, 1999). In order to ascertain or rule out this hypothesis, the cells were
treated with ZMP and a blocker of the purinergic receptors, 8GPT. This showed to
have no effect on the phosphorylation of AMPK elicited by ZMP (see Fig 4.19) ruling
out the involvement of purinergic receptors in the effect of ZMP on AMPK
phosphorylation in cardiomyocytes.
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5.2 GLUCOSE UPTAKE
An increase in AMPK activity leads to stimulation of glucose uptake in skeletal
muscle (Merrill et aI, 1997; Hayashi et aI, 1998). However, the significant AMPK
phosphorylation noted in our study was not accompanied by a concomitant increase
in cardiomyocyte glucose uptake (see Fig 4.5 and Fig 4.6). On the contrary, there
was a significant decrease in glucose uptake seen in both the AlGAR and ZMP
treated cardiomyocytes.
This is similar to work by Jessen et al (2002) where he showed that, although AlGAR
increased insulin-stimulated glucose uptake in a fiber specific manner (higher in type
" muscle fibers than type I fibers), basal non-insulin stimulated glucose transport in
AlGAR exposed animals was significantly lower in all muscles when compared with
controls and exercised animals. Our findings are consistent with the results of Jessen
et al in that AlGAR stimulation alone decreased basal glucose uptake. Additionally,
in recent work, AI-Khalili et al (2004) showed that AIGAR-induced AMPK activation in
primary human skeletal myocytes does not lead to a subsequent increase in glucose
uptake. This work was done on both chronic and short-term exposure to 2mM
AlGAR.
However, in contrast to the above, Russell et al (1999) showed that in heart papillary
muscle incubations with AlGAR increased glucose uptake almost twofold and led to
AMPK phosphorylation and GLUT4 translocation. The concentration of AlGAR used
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both in this study and by Russell and coworkers was 1 mM. Both in this study and in
their study, the cells or muscle were incubated for 30 minutes prior to the addition of
2DG. However, Russell and colleagues incubated the papillary muscle with the 2DG
for a further 60 minutes, whereas in our study it was only incubated for 30 minutes
after the addition of 2DG. The incubation medium used in our study was a HEPES
based buffer, and Russell et al used a PBS medium. These differences in protocol as
well as the difference in model, might serve as some explanation for the differences
in results.
In addition to the effects of AlGAR and ZMP on cardiomyocyte glucose uptake, pre-
treatment with the drugs attenuated insulin (100 nM) -stimulated glucose uptake. This
is contrary to the findings of Fisher et al (2002) who found that the activation of
AMPK enhanced the sensitivity of skeletal muscle glucose transport to insulin.
However, our findings are similar to the previously mentioned work by AI-Khalili et al
(2004), who also found that AlGAR-induced AMPK activation in human skeletal
myocytes did not lead to a subsequent increase in insulin-stimulated glucose uptake,
in fact it lead to a 16-17% decrease in insulin-stimulated glucose uptake.
This attenuation was not seen, however, when we reversed the protocol and gave
insulin to the cells only 5 minutes before AlGAR or ZMP (see Fig 4.7). A maximal
insulin-stimulated glucose uptake is seen at 7 minutes according to Somwar et al
(2001), with a two-fold increase in basal glucose uptake occurring at 5 minutes
already. Thus, in view of this rapid response, it appears that AlGAR and ZMP
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inhibition of insulin-stimulated glucose uptake can no longer occur. These
observations suggest that AICAR and ZMP stimulation, when preceding insulin
stimulation, unleashed as yet unidentified inhibitory effects on glucose uptake.
According to Shearer and colleagues (2004), using an in vivo perfusion system,
stimulation of AMPK with AICAR leads to a rapid translocation of FAT/CD36 and
uptake of fatty acids into the heart. This will inhibit glucose uptake, according to the
mechanism of Randle (1963). However, in our system of measuring glucose uptake,
glycolysis is inhibited by the presence of 2DG, therefore we measured glucose taken
up by the GLUT4. Inhibition via the uptake and metabolism offatty acids is therefore
not a plausible explanation. Furthermore our system contains fatty acid free BSA that
will sequester all fatty acids in the system, ruling out any role for fatty acids in our
cardiomyocyte model.
5.3 PKB/Akt phosphorylation
Since insulin stimulates glucose uptake (Fischer et ai, 1991; Berger et ai, 1994), and
so does AMPK (Fryer et ai, 2000; Hyashi et ai, 1998) by translocation of GLUT4 to
the cell membrane (Fischer et ai, 1997; Russell et ai, 1999) it is very likely that cross
talk occurs between these two pathways of glucose uptake. Although not much is
known about the cross-talk between AMPK-stimulated and insulin-stimulated glucose
uptake pathways, it was reported that stimulation of the AMPK glucose uptake
pathway enhances the sensitivity of skeletal muscle glucose transport to insulin
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stimulation (Fisher et aI, 2002) involving a step beyond PKB in the insulin-stimulated
pathway. In contrast it was also reported by Beauloye et al (2001) that pre-treatment
of isolated hearts with 100 nM insulin antagonized the activation of AMPK during
ischaemia at 5 minutes and onwards, showing definite inhibitory cross-talk between
pathways.
For this reason, PKB/Akt phosphorylation was also analysed in this study (see Fig
4.9 to Fig 4.12). It was found that the basal stimulation of PKB\Akt was not inhibited
by AICAR or ZMP, despite the observed inhibition of basal glucose uptake. This
agrees with the viewpoint that basal glucose uptake is not a GLUT4 mediated event,
therefore not dependent on PKB/Akt activation. Interestingly, the effect of pre-
treatment with AICAR or ZMP on insulin stimulation of PKB/Akt phosphorylation was
the same as that of insulin alone, not showing the attenuation seen in glucose
uptake. Thus the inhibitory action of AICAR and ZMP on insulin-stimulated glucose
uptake has its effect downstream from PKB/Akt phosphorylation.
5.4 Effect of Wortmannin
The fungal inhibitor wortmannin is a potent inhibitor of PI3-K activity (Stoyanova et aI,
1997) and therefore has downstream effects inhibiting PKB/Akt phosphorylation. It
was also reported by Jakobsen et al (2001) that AMPK, in response to AICAR, had
the ability to phosphorylate IRS-1 on Ser-789 in mouse C2C12 myotubes suggesting
an upstream link between the insulin-stimulated pathway and the AMPK pathway of
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glucose uptake. We therefore decided to treat cells with wortmannin in combination
with AICAR or ZMP and insulin and noted the effects (see Fig 4.13 to Fig 4.18).
5.4.1 Effect on Glucose Uptake
As was expected, wortmannin inhibited all insulin stimulated glucose uptake back to
basal levels. This is consistent with the findings of others (Berger et ai, 1994; Ueki et
ai, 1998). The presence of wortmannin did not alter the inhibitory effect of AICAR and
ZMP on cardiomyocyte glucose uptake (see figures 4.13 and 4.14), indicating that
PI3-K is not involved in these reactions.
5.4.2 Effect on PKB phosphorylation
AICAR and ZMP supposedly act via activation of AMPK, an event not associated with
activation of PI3-K as discussed above. Interestingly, our work showed that in cells
stimulated with ZMP in the presence of wortmannin, there was an unexpected
significant increase in PKB/Akt phosphorylation. This same increase could be seen in
PKB/Akt phosphorylation in the presence of AICAR and wortmannin, although it was
not as outspoken. This can perhaps be explained by an effect of AICAR and ZMP on
PKB/Akt phosphatases, where the dephosphorylation of PKB/Akt is diminished and
the effect thereof is only unmasked in the presence of inhibition of further
phosphorylation of PKB/Akt via PI3-K. It may of course also be the result of the
actions of some unknown kinase only triggered by the abovementioned combination.
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It is well known that wortmann in inhibits PKB/Akt phosphorylation via inhibition of
PI3-K (Ng et al, 2001) and our findings are consistent with this (see figure 4.15 to
4.18) in that insulin-stimulated PKB/Akt phosphorylation was blocked by wortmannin
administration to cardiomyocytes, having no effect on basal phosphorylation. As this
study showed that the effects of both AICAR and ZMP on insulin-stimulated glucose
uptake lie downstream of PKB/Akt phosphorylation in the signaling cascade, no
effect of wortmannin on this event was expected. There is no literature to date
describing the effect of wortmannin on AICAR and ZMP stimulated PKB/Akt
phosphorylation in cardiomyocytes.
In the presence of AICAR or ZMP, wortmannin was also not able to totally abolish
insulin stimulated PKB/Akt phosphorylation confirming an effect of these substances
in modifying the PKB/Akt phosphorylation state. However the exact mechanism of
this observation and the importance thereof would only be shown through further
research.
5.5 GLUT 4 Translocation
GLUT4s are the glucose transporters recruited to the cell membrane in response to
insulin stimulation (Fischer et aI, 1997; Calera et aI, 1998; Becker et aI, 2001). They
are also reported to be up regulated in response to AMPK activation by a single
subcutaneous injection of AICAR (1mg/g body weight) peaking at 13 hours post-
injection (Zheng et aI, 2001; Holmes et aI, 1999) and translocate to the cell
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membrane to enhance glucose uptake during muscle contraction (Till et aI, 1997). In
heart papillary muscle, AICAR stimulated AMPK activation (Russell et aI, 1999) also
leads to GLUT4 translocation. In view of the observation made in this study that
these drugs stimulate AMPK activation but not glucose uptake, it was decided to
investigate the content of GLUT4 in cytosolic and membrane compartments of
isolated myocytes and in perfused hearts to quantify the movement of GLUT4 after
various stimuli.
5.5.1 GLUT4 content in the cytosol in isolated cardiomyocytes
Both ZMP and AICAR stimulated cardiomyocytes showed a significant decrease in
cytosolic GLUT4 content, indicating that the transporters moved away from the
cytosol in response to AICAR and ZMP stimulation (see Fig 4.21 & Fig 4.22). We
have no explanation why such variable results were found with insulin, using the
same experimental protocol, but it is possibly due to significantly elevated amounts of
GLUT4 present in the cytosol, which makes it very difficult to quantify removal of
small quantities.
5.5.2 GLUT4 content in the membrane in isolated cardiomyocytes
An increase in GLUT4 content was found after stimulation with insulin, AICAR and
ZMP in the membrane compartment (see Fig 4.23 & Fig 4.24). We therefore
conclude that GLUT4 translocation indeed occurred from the cytosolic compartment
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to the membrane in insulin, AICAR- and ZMP-stimulated cardiomyocytes, even
though no glucose uptake was elicited with either AICAR or ZMP. When insulin was
added to myocytes pre-treated with either AICAR or ZMP, a significant increase in
GLUT4 translocation could only be seen with the combination of insulin and AICAR.
5.5.3 GLUT4 content in the whole heart
As can be seen in Figures 4.26 & 4.29, no significant differences in GLUT4 content
could be seen in cytosolic compartments in insulin-, AICAR- or ZMP-stimulated
hearts, regardless of whether the perfusate contained glucose (5 mM) or not. When
looking at the membrane fractions of both 5mM and glucose free perfused hearts, a
definite tendency could be seen towards GLUT4 translocation to the membrane (see
Fig 4.27, 4.28 & 4.30). Unfortunately the standard errors of these groups were very
high, not allowing for these increases in translocation to be significant. This could be
due to the fact that the technique for isolation and purification of sarcolemmal
membrane is a rather crude method that does not yield enough protein for analysis. It
is suggested that a more stringent and accurate method be developed and used to
refute or prove the results obtained. However, the convincing results obtained with
the cardiomyocyte preparation, lead us to believe that AICAR and ZMP do indeed
cause translocation of GLUT4 from the cytosol to the sarcolemma.
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5.6 Glucose uptake versus GLUT4 translocation
The two major findings of the current study is that (i) neither AICAR nor ZMP could
stimulate glucose uptake in isolated cardiomyocytes while both substances were able
to phosphorylate AMPK and elicit translocation of the GLUT4 transporter from the
cytosol to the cell membrane and (ii) both AICAR and ZMP inhibited insulin
stimulated glucose uptake while insulin-induced translocation of GLUT4 was not
affected.
These findings highlight the concept put forward by the group of Amira Klip (Furtado
et ai, 2002) that GLUT4 translocation and GLUT4 activation to transport glucose are
two independent, though interrelated occurrences that can be separated from one
another. To substantiate this statement, Sweeney et al (2004) demonstrated that
intracellular delivery of PIP3 results in GLUT4 translocation and incorporation into the
membrane, but no associated glucose uptake while Funaki et al (2004) created a
cell-permeable phosphoinositide-binding peptide that could induce GLUT4
translocation to the plasma membrane in adipocytes, without increasing glucose
uptake. This has lead investigators to search for the second signal involved in the
activation of glucose transport, as discussed below.
Using isolated ventricular cardiomyocytes for measurement of both GLUT4
translocation and glucose uptake, it is apparent that insulin has the ability to stimulate
both translocation and activation of GLUT4 while AICAR and ZMP stimulate GLUT4
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translocation but not activation. It would also seem as if, once AlGAR and ZMP have
accomplished this translocation, insulin loses its ability to activate the transporters,
the mechanism of which remains to be established. On the other hand, once
translocation by insulin has been accomplished (according to Somwar et al (2001)
this takes less than 5 minutes), AlGAR and ZMP have no effect. Glearly further work
is required to elucidate the mechanisms involved. We are currently developing a flow
cytometric analyses of GLUT4 translocation in cardiomyocytes using a cell
impermeable probe that binds only to translocated GLUT4 on the outer membrane
surface. This has only become available after completion of the current project.
5.6.1 p38 MAPK
A study by Xi et aI, (2001) reported that AMPK stimulated glucose uptake via p38
MAPK activity. These findings were supplemented by Somwar et al (2001) who found
that a dominant negative p38 MAPK mutant and selective inhibitors of p38 MAPK
reduce insulin-stimulated glucose uptake in adipocytes without affecting GLUT4
translocation. Furthermore Lemieux et al (2003) showed that AlGAR stimulated p38
activation in skeletal muscle.
For these reasons we treated cells with the p38 inhibitor SB 203580, measuring the
effect on glucose uptake, in the presence of ZMP. In cardiomyocytes, we did not
observe any effect on the inhibition of glucose uptake by ZMP. Thus it was concluded
that p38 MAPK activation does not playa role in our observations.
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Role of NOS?
In a recent publication by Li et al (2004), it was proposed that nitric oxide might playa
role in AMPK-mediated glucose uptake and GLUT4 translocation. It has been
described before that AMPK phosphorylates endothelial nitric oxide synthase (eNOS)
on Ser1177 (Chen et ai, 1999, Chen et ai, 2000) leading to NOS activation. This was
confirmed by Li et al (2004). Several studies have indicated that insulin activates
endothelial NOS via protein kinase B (PKB/Akt)-mediated phosphorylation at Ser1177
in endothelial cells (Trovati et ai, 1999; Ribiere et ai, 2002). In skeletal muscle from
mice deficient in eNOS, there is decreased insulin stimulated glucose uptake,
suggesting that activation of nitric oxide by PKB/Akt may playa key role in glucose
uptake (Browne et al, 1999; Duplain et al, 2001). Shearer et al (2004) and Fryer et al
(2000) showed that NOS inhibition with L-NAME (~-nitro-L-arginine) in skeletal
muscle reduced AICAR stimulated glucose uptake. Li and coworkers (2004)
incubated rat left ventricular papillary muscle with AICAR (1mM) and found increased
glucose uptake and GLUT4 translocation along with the increased eNOS
phosphorylation. Low concentrations of nitric oxide donors were found to increase
papillary muscle glucose uptake as well as GLUT4 translocation, and NOS inhibitors
partially blocked AICAR stimulated glucose uptake.
According to the available literature, activation of eNOS is an event occurring
downstream of PKB/Akt phosphorylation after stimulation with insulin (Salt et a/,2003;
Kim et ai, 2001), making this a possible candidate. It is possible that in a myocyte
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preparation, the available eNOS is not able to produce enough NO to trigger GLUT4
activation. In contrast, in papillary muscle, endothelial eNOS may playa major role,
supplying the necessary NO. This would explain why glucose uptake takes place on
stimulation with AICAR in a papillary muscle model but not in the isolated myocyte
preparation. We will be able to test this possibility by supplying isolated
cardiomyocytes with nitric oxide donors in conjunction with stimulation with AICAR
and ZMP to see whether such treatment will induce glucose uptake.
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CONCLUSION
In conclusion, treatment of cardiomyocytes with AICAR and ZMP, two AMPK-
activating pharmacological agents, did not result in an increased glucose uptake. In
fact, both AICAR and ZMP resulted in a decreased glucose uptake response, even
though PKB/Akt phosphorylation and GLUT4 translocation were evident in both
AICAR and ZMP treated cells. An attenuated insulin-stimulated glucose uptake was
shown when AICAR or ZMP were given to cells before insulin, and this affect was
absent when cells were stimulated with insulin before AICAR or ZMP. This
attenuation was also not seen in the PKB/Akt phosphorylation patterns. An increase
in phosphorylation of PKB/Akt was shown when cardiomyocytes were pre-treated
with wortmannin and then stimulated with ZMP.
Our results, and those of others lead us to speculate that for AICAR or ZMP to induce
glucose uptake, the whole muscle needs to be present, and individual isolated
myocytes cannot be stimulated by these substances to induce increased glucose
uptake. It is possible that the presence of endothelial cells may play a large role in
these whole muscle preparations.
Finally, the mechanism whereby AICAR and ZMP inhibit activation of the GLUT4
transporter after its translocation to the cell membrane remains to be established. In
order to do so, a more sensitive technique to measure GLUT4 translocation in heart
or myocytes, needs to be developed.
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